<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id>
<journal-id journal-id-type="iso-abbrev">Dis Model Mech</journal-id>
<journal-id journal-id-type="publisher-id">DMM</journal-id>
<journal-id journal-id-type="hwp">dmm</journal-id>
<journal-title-group>
<journal-title>Disease Models &amp; Mechanisms</journal-title>
</journal-title-group>
<issn pub-type="ppub">1754-8403</issn>
<issn pub-type="epub">1754-8411</issn>
<publisher>
<publisher-name>The Company of Biologists Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31043432</article-id>
<article-id pub-id-type="pmc">6550036</article-id>
<article-id pub-id-type="doi">10.1242/dmm.037044</article-id>
<article-id pub-id-type="publisher-id">DMM037044</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Zebra</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Vascular defects of <italic>DYRK1A</italic> knockouts are ameliorated by modulating calcium signaling in zebrafish</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Hyun-Ju</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Jae-Geun</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jong-Hwan</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Seon-Young</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huh</surname>
<given-names>Yang Hoon</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hyo-Jeong</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Kyu-Sun</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Kweon</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-8491-4429</contrib-id>
<name>
<surname>Lee</surname>
<given-names>Jeong-Soo</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>Disease Target Structure Research Center</institution>, <addr-line>Korea Research Institute of Bioscience and Biotechnology</addr-line>, <addr-line>125 Gwahak-ro, Yuseong-gu, Daejeon, 34141</addr-line>, <country>Republic of Korea</country></aff>
<aff id="af2"><label>2</label><institution>KRIBB School, University of Science and Technology</institution>, <addr-line>125 Gwahak-ro</addr-line>, <addr-line>Yuseong-gu, Daejeon, 34141</addr-line>, <country>Republic of Korea</country></aff>
<aff id="af3"><label>3</label><addr-line>Dementia DTC R&amp;D Convergence Program</addr-line>, <institution>Korea Institute of Science and Technology</institution>, <addr-line>Hwarang-ro 14-gil 5, Seongbuk-gu, Seoul, 02792</addr-line>, <country>Republic of Korea</country></aff>
<aff id="af4"><label>4</label><institution>Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology</institution>, <addr-line>125 Gwahak-ro, Yuseong-gu, Daejeon, 34141</addr-line>, <country>Republic of Korea</country></aff>
<aff id="af5"><label>5</label><institution>Electron Microscopy Research Center, Korea Basic Science Institute</institution>, <addr-line>162 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, 28119</addr-line>, <country>Republic of Korea</country></aff>
<aff id="af6"><label>6</label><institution>Hazards Monitoring BNT Research Center</institution>, <addr-line>Korea Research Institute of Bioscience and Biotechnology</addr-line>, <addr-line>125 Gwahak-ro, Yuseong-gu, Daejeon, 34141</addr-line>, <country>Republic of Korea</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Author for correspondence (<email>jeongsoo@kribb.re.kr</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>5</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the epub date downloaded from Highwire. -->
<volume>12</volume>
<issue>5</issue>
<elocation-id>dmm037044</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="https://creativecommons.org/licenses/by/4.0">https://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="dmm-12-037044.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p><italic>DYRK1A</italic> is a major causative gene in Down syndrome (DS). Reduced incidence of solid tumors such as neuroblastoma in DS patients and increased vascular anomalies in DS fetuses suggest a potential role of <italic>DYRK1A</italic> in angiogenic processes, but <italic>in vivo</italic> evidence is still scarce. Here, we used zebrafish <italic>dyrk1aa</italic> mutant embryos to understand <italic>DYRK1A</italic> function in cerebral vasculature formation. Zebrafish <italic>dyrk1aa</italic> mutants exhibited cerebral hemorrhage and defects in angiogenesis of central arteries in the developing hindbrain. Such phenotypes were rescued by wild-type <italic>dyrk1aa</italic> mRNA, but not by a kinase-dead form, indicating the importance of DYRK1A kinase activity. Chemical screening using a bioactive small molecule library identified a calcium chelator, EGTA, as one of the hits that most robustly rescued the hemorrhage. Vascular defects of mutants were also rescued by independent modulation of calcium signaling by FK506. Furthermore, the transcriptomic analyses supported the alterations of calcium signaling networks in <italic>dyrk1aa</italic> mutants. Together, our results suggest that <italic>DYRK1A</italic> plays an essential role in angiogenesis and in maintenance of the developing cerebral vasculature via regulation of calcium signaling, which may have therapeutic potential for <italic>DYRK1A</italic>-related vascular diseases.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> The roles of DYRK1A in angiogenesis and maintenance of the developing cerebral vasculature mediated by calcium signaling were revealed using zebrafish <italic>dyrk1aa</italic> knockout mutants.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>DYRK1A</kwd>
<kwd>Vascular development</kwd>
<kwd>Hemorrhage</kwd>
<kwd>Zebrafish embryo</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Research Foundation of Korea</institution>
<institution-id>http://dx.doi.org/10.13039/501100003725</institution-id>
</institution-wrap>
</funding-source>
<award-id>NRF-2011-0023507</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Research Council of Science &amp; Technology</institution>
<institution-id>http://dx.doi.org/10.13039/501100008783</institution-id>
</institution-wrap>
</funding-source>
<award-id>CRC-15-04-KIST</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Ministry of Science, ICT and Future Planning</institution>
<institution-id>http://dx.doi.org/10.13039/501100003621</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Korea Research Institute of Bioscience and Biotechnology</institution>
<institution-id>http://dx.doi.org/10.13039/501100003715</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>INTRODUCTION</title>
<p>The cerebral vasculature plays an essential role in maintaining the homeostasis of the brain by providing oxygen and nutrients and removing waste products. During development, new branches of the cerebral vasculature are formed through angiogenesis by endothelial cells, the primary cell component of the vasculature, via complex cell-cell interactions and signaling pathways from existing vessels (<xref ref-type="bibr" rid="DMM037044C82">Udan et al., 2013</xref>). The cerebral vasculature also contributes to the formation of the neurovascular unit (NVU), which comprises pericytes, astrocytes, microglia and neurons in addition to endothelial cells. Compromise of the normal development or function of the NVU has been implicated in childhood brain development disorders and adult neurological dysfunction (<xref ref-type="bibr" rid="DMM037044C65">Quaegebeur et al., 2011</xref>; <xref ref-type="bibr" rid="DMM037044C90">Zlokovic, 2008</xref>). In the NVU, cerebral endothelial cells, connected mainly by tight junction proteins, build the blood-brain barrier that acts as a primary semipermeable barrier and confers a high selectivity for molecular exchanges between the blood and the brain parenchyma (<xref ref-type="bibr" rid="DMM037044C14">Dejana et al., 2009</xref>). Therefore, the inappropriate development of cerebral endothelial cells may lead to defects in angiogenesis and/or endothelial permeability, which are closely linked to vascular pathologies such as vascular malformations and stroke (<xref ref-type="bibr" rid="DMM037044C20">Folkman, 1995</xref>; <xref ref-type="bibr" rid="DMM037044C62">Pandya et al., 2006</xref>).</p>
<p>The development of the brain vasculature is coordinated by various extra- and intracellular signals. Among them, calcium signaling is one of the major regulators of vascular development and related pathogenesis. Vascular endothelial growth factor signals and various stimuli trigger the change of intracellular Ca<sup>2+</sup> levels that act as second messengers in endothelial cells, which in turn affect the activity of transcription factors for angiogenesis, such as nuclear factor of activated T-cells, via Ca<sup>2+</sup>-dependent calmodulin/calcineurin activity (<xref ref-type="bibr" rid="DMM037044C36">Hogan et al., 2003</xref>; <xref ref-type="bibr" rid="DMM037044C49">Loh et al., 1996</xref>). In addition, an overload of Ca<sup>2+</sup> can cause endothelial barrier dysfunction; intracellular Ca<sup>2+</sup> release via activation of IP<sub>3</sub> receptors (IP3R) or ryanodine receptors (RyRs) of the endoplasmic reticulum into the cytoplasm can increase vascular permeability through disorganization of VE-cadherin (Cdh5) or cytoskeletal rearrangement (<xref ref-type="bibr" rid="DMM037044C23">Gao et al., 2000</xref>; <xref ref-type="bibr" rid="DMM037044C73">Shen et al., 2010</xref>; <xref ref-type="bibr" rid="DMM037044C80">Tiruppathi et al., 2002</xref>). Intriguingly, it has been reported that calcium supplementation for bone health can unexpectedly induce stroke and cardiovascular diseases (<xref ref-type="bibr" rid="DMM037044C68">Reid and Bolland, 2008</xref>), and calcium channel blockers and calcium antagonists have been clinically used as therapeutic agents for strokes and blood vessel dysfunction (<xref ref-type="bibr" rid="DMM037044C39">Inzitari and Poggesi, 2005</xref>). Thus, understanding the detailed underlying molecular mechanisms of Ca<sup>2+</sup> signaling in angiogenesis and vascular permeability along with the identification of key players may provide an important therapeutic means for treating vascular diseases.</p>
<p>Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a serine-threonine kinase that has a dual kinase activity capable of autophosphorylating its own tyrosine residues and phosphorylating other substrates. The <italic>DYRK1A</italic> gene was first identified in a <italic>Drosophila</italic> screening as a mutant <italic>minibrain</italic>, named for the brain morphology defects with reduced brain size (<xref ref-type="bibr" rid="DMM037044C76">Tejedor et al., 1995</xref>). <italic>DYRK1A</italic> is located in a Down syndrome critical region (DSCR) and is best known as a major causative gene that is implicated in brain function, neurological defects and neurofibrillary tangle formation in Down syndrome (DS) (<xref ref-type="bibr" rid="DMM037044C48">Liu et al., 2008</xref>; <xref ref-type="bibr" rid="DMM037044C87">Wegiel et al., 2011</xref>).</p>
<p>Interestingly, epidemiological studies suggested that DS patients have a reduced incidence of angiogenesis-related solid tumors (<xref ref-type="bibr" rid="DMM037044C32">Hasle et al., 2000</xref>; <xref ref-type="bibr" rid="DMM037044C59">Nižetić and Groet, 2012</xref>) and carry numerous vascular anomalies such as umbilico-portal system anomalies, vertebral and right subclavian artery defects, and pulmonary vein stenosis (<xref ref-type="bibr" rid="DMM037044C27">Gowda et al., 2014</xref>; <xref ref-type="bibr" rid="DMM037044C64">Pipitone et al., 2003</xref>; <xref ref-type="bibr" rid="DMM037044C67">Rathore and Sreenivasan, 1989</xref>; <xref ref-type="bibr" rid="DMM037044C75">Stewart et al., 1992</xref>). Furthermore, they also have an increased incidence of Moyamoya disease and cerebral amyloid angiopathy, which are associated with a cerebrovascular dysfunction and intracerebral hemorrhage (<xref ref-type="bibr" rid="DMM037044C13">de Borchgrave et al., 2002</xref>; <xref ref-type="bibr" rid="DMM037044C18">Donahue et al., 1998</xref>; <xref ref-type="bibr" rid="DMM037044C41">Jastrzebski et al., 2015</xref>; <xref ref-type="bibr" rid="DMM037044C56">Mito and Becker, 1992</xref>; <xref ref-type="bibr" rid="DMM037044C71">Sabde et al., 2005</xref>). Consistent with the potential role of <italic>DYRK1A</italic> in angiogenesis, the TS65Dn mouse model of DS, trisomic for the <italic>Dyrk1a</italic> gene, exhibited reduced tumor growth, presumably by suppressing tumor angiogenesis (<xref ref-type="bibr" rid="DMM037044C3">Baek et al., 2009</xref>). Although vascular defects had not been directly associated with human <italic>DYRK1A</italic> haploinsufficiency syndrome, it has been reported that nearly 75% of children with autism, some of which may have <italic>DYRK1A</italic> mutations or its reduced activity (<xref ref-type="bibr" rid="DMM037044C44">Kim et al., 2017</xref>), exhibited hypoperfusion in the brain detected by neuroimaging (<xref ref-type="bibr" rid="DMM037044C7">Bjorklund et al., 2018</xref>; <xref ref-type="bibr" rid="DMM037044C89">Zilbovicius et al., 2000</xref>). Also, retinal angiogenesis is disrupted in <italic>Dyrk1a</italic> heterozygote mice (<xref ref-type="bibr" rid="DMM037044C70">Rozen et al., 2018</xref>), suggesting a role of <italic>DYRK1A</italic> loss-of-function in regulating angiogenesis in the brain. Taken together, <italic>DYRK1A</italic> may be implicated in vascular formation and/or function, and this could provide a new perspective to understanding <italic>DYRK1A</italic>-related pathogenesis; however, <italic>in vivo</italic> evidence of <italic>DYRK1</italic>A function in vascular pathology is scarce.</p>
<p>To investigate the role of <italic>DYRK1A</italic> in vascular formation, we adopted developing zebrafish as a model organism. Zebrafish is a vertebrate animal model used for genetic studies of human diseases exhibiting a high similarity to humans at anatomical and molecular levels, especially in the vascular and nervous system (<xref ref-type="bibr" rid="DMM037044C40">Isogai et al., 2001</xref>; <xref ref-type="bibr" rid="DMM037044C72">Schmidt et al., 2013</xref>). Zebrafish embryos can be readily manipulated for genetic gain-of-function studies with transgenesis or mRNA overexpression, and loss-of-function studies with gene knockouts or morpholino use (<xref ref-type="bibr" rid="DMM037044C11">Clark et al., 2011</xref>; <xref ref-type="bibr" rid="DMM037044C37">Hogan et al., 2008</xref>; <xref ref-type="bibr" rid="DMM037044C79">Timme-Laragy et al., 2012</xref>; <xref ref-type="bibr" rid="DMM037044C84">Varshney et al., 2015</xref>; <xref ref-type="bibr" rid="DMM037044C91">Zu et al., 2013</xref>). Large clutch sizes and various inexpensive and fast experimental techniques allow the use of zebrafish for unique high-throughput <italic>in vivo</italic> small molecule screening, which enables the identification of hit compounds and gives insights into potential underlying mechanisms (<xref ref-type="bibr" rid="DMM037044C51">MacRae and Peterson, 2015</xref>).</p>
<p>We have recently reported autistic behavioral phenotypes of knockout mutants of <italic>dyrk1aa</italic>, a mammalian <italic>DYRK1A</italic> homolog, named <italic>dyrk1aa<sup>krb1</sup></italic>, generated by transcription activator-like effector nucleases (<xref ref-type="bibr" rid="DMM037044C44">Kim et al., 2017</xref>). In the current study, we investigated a role of <italic>DYRK1A</italic> in cerebrovascular development during embryogenesis using the <italic>dyrk1aa</italic> loss-of-function mutants. The <italic>dyrk1aa<sup>krb1</sup></italic> mutants exhibited cerebral hemorrhage and angiogenic defects in the developing hindbrain, as analyzed at high resolution by confocal fluorescent microscopy using transgenic animals and transmission electron microscopy. These vascular abnormalities were rescued by expression of wild-type (WT) <italic>dyrk1aa</italic> mRNA, but not a kinase-dead form, indicating an essential role of its kinase activity. Chemical screening using a US Food and Drug Administration (FDA)-approved chemical library identified the calcium chelator ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) that efficiently rescued cerebral hemorrhage as well as abnormal cerebrovascular defects in <italic>dyrk1aa</italic> mutants. Another calcium signaling modulator, FK506, rescued the hemorrhagic and cerebrovascular defects of <italic>dyrk1aa</italic> mutants in a similar manner as EGTA, and transcriptomic analyses identified changes in calcium signaling as the main pathway affected in <italic>dyrk1aa</italic> mutants. Together, the cerebral hemorrhage and cerebrovascular defects of zebrafish <italic>dyrk1aa</italic> mutants and the chemical screening revealed an important but less-known role of <italic>DYRK1A</italic> in <italic>in vivo</italic> vascular formation, which involves a mechanism that is mediated by calcium signaling, providing a potential therapeutic target for <italic>DYRK1A</italic>-related vascular disorders.</p>
</sec>
<sec id="s2" sec-type="results">
<title>RESULTS</title>
<sec id="s2a">
<title>Cerebral hemorrhage and a vascular phenotype of <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos</title>
<p>We recently reported the generation of the <italic>dyrk1aa<sup>krb1</sup></italic> mutants that displayed microcephaly and autistic behavioral phenotypes in adults, whereas no distinct morphological defects were observed during embryogenesis (<xref ref-type="bibr" rid="DMM037044C44">Kim et al., 2017</xref>). Detailed inspection of <italic>dyrk1aa<sup>krb1</sup></italic> homozygous mutant embryos, however, revealed a cerebral hemorrhage phenotype as early as 52 h postfertilization (hpf) (arrows in <xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>A). Of the offspring of <italic>dyrk1aa<sup>krb1</sup></italic> mutants, 27.9% of a clutch displayed cerebral hemorrhage, whereas less than 9.9% of WT offspring showed spontaneous hemorrhage at 52 hpf using <italic>o</italic>-dianisidine staining, which detects hemoglobin activity and allows observation of cerebral hemorrhage more closely (<xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>B). Spontaneous hemorrhage of WT offspring at 52 hpf was detected in less than 5% of the clutch under the brightfield microscope (without <italic>o</italic>-dianisidine staining, data not shown). Cerebral hemorrhage was detected as patches in the forebrain, midbrain, hindbrain and retina, with some embryos exhibiting multiple hemorrhages simultaneously (<xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>A). To obtain more pronounced hemorrhagic effects and observe a more explicit phenotype, we challenged the mutant embryos with heat stress by incubation at 35°C for 2.5 h from 48 hpf to 50.5 hpf, followed by keeping them at 28.5°C until 52 hpf. The following experiments for hemorrhagic phenotype were performed in the heat stress condition. It has been previously reported that cardiovascular stress aggravates the hemorrhagic phenotype in the brain, presumably by increasing the heart rate (<xref ref-type="bibr" rid="DMM037044C5">Barrionuevo and Burggren, 1999</xref>; <xref ref-type="bibr" rid="DMM037044C86">Wang et al., 2014</xref>). Consistently, the cerebral hemorrhage of WT and <italic>dyrk1aa<sup>krb1</sup></italic> mutants under the heat-stressed condition increased by 16.3% and 40.5%, respectively (<xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>B, Heat-stressed).
<fig id="DMM037044F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold><italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos show cerebral hemorrhagic phenotype and abnormal development of CtAs in the brain.</bold> (A) Cerebral hemorrhage was observed in <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos (<italic>dyrk1aa<sup>krb1</sup></italic>) at 52 hpf (Ac-Af, arrows) compared to WT (Aa, Ab). Aa,Ac,Ae show the lateral view; Ab,Ad,Af show the dorsal view. (B) Embryonic cerebral hemorrhage of WT occurred spontaneously in 9.9% of embryos, whereas <italic>dyrk1aa<sup>krb1</sup></italic> embryos showed cerebral hemorrhage of 27.9% penetrance (Normal), using <italic>o</italic>-dianisidine staining. The cerebral hemorrhage of WT and <italic>dyrk1aa<sup>krb1</sup></italic> mutants increased up to 16.3% and 40.5%, respectively, by inducing heat stress with 2.5 h incubation at 35°C from 48-50.5 hpf (Heat-stressed). The mean percentages for each genotype were presented from four independent experiments with approximately 20 embryos for each repeat. (C) Confocal fluorescent images at 52 hpf showing the development of CtAs in WT and <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos in the <italic>Tg(kdrl:EGFP)</italic> background. (D) The lengths and branching points of CtAs in <italic>dyrk1aa<sup>krb1</sup></italic> mutants were reduced down to 70.2% and 73.3%, respectively, compared to the WT embryos as 100% at 52 hpf. *<italic>P</italic>&lt;0.05, ***<italic>P</italic>&lt;0.005 (Mann–Whitney <italic>U</italic> test). Data are mean±s.e.m. fb, forebrain; mb, midbrain; hb, hindbrain; e, eye; y, yolk. Scale bar: 250 µm in A; 50 µm in C.</p></caption><graphic xlink:href="dmm-12-037044-g1"></graphic></fig></p>
<p>Because cerebral hemorrhage is sometimes accompanied by defective cerebrovascular formation (<xref ref-type="bibr" rid="DMM037044C2">Arnold et al., 2014</xref>), we examined the formation of central arteries (CtAs) in the hindbrain, a well-characterized stereotypical developing cerebrovascular structure, using <italic>Tg(kdrl:EGFP)</italic> transgenic animals (<xref ref-type="bibr" rid="DMM037044C83">Ulrich et al., 2011</xref>) in the WT or <italic>dyrk1aa<sup>krb1</sup></italic> mutants. CtAs sprouted from the primordial hindbrain channels, which contained the pool of endothelial cells required for CtA formation, and invaded the hindbrain between 32 and 36 hpf with a stereotypical morphology within rhombomeres, formed with over 50% ipsilateral CtA connectivity at 48 hpf (<xref ref-type="bibr" rid="DMM037044C8">Bussmann et al., 2011</xref>; <xref ref-type="bibr" rid="DMM037044C83">Ulrich et al., 2011</xref>). A detailed, high-resolution confocal imaging analysis to compare the CtA formation of <italic>dyrk1aa<sup>krb1</sup></italic> mutants and WT at 52 hpf revealed that the stereotypical structure of CtAs was abolished in <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos (<xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>C). To quantitate the CtA vascular defects, the length and branching points of CtAs were measured, representing the migration/proliferation and sprouting activities of CtA endothelial cells, respectively (<xref ref-type="bibr" rid="DMM037044C1">AlMalki et al., 2014</xref>; <xref ref-type="bibr" rid="DMM037044C63">Phng et al., 2009</xref>; <xref ref-type="bibr" rid="DMM037044C78">Tímár et al., 2001</xref>) (<xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>D). In <italic>dyrk1aa<sup>krb1</sup></italic> mutants, the total lengths and branching points of CtAs were reduced to 70.2% and 73.3% compared to the WT control, respectively (<xref ref-type="fig" rid="DMM037044F1">Fig. 1</xref>D). In the following experiments, we used the length and branching points of CtAs as quantitative measures of defects in vascular development.</p>
<p>CtA angiogenic defects were also confirmed by examining RNA expression of vascular markers <italic>kdrl</italic> (<italic>vegfr2</italic>) and <italic>dll4</italic> by whole-mount RNA <italic>in situ</italic> hybridization (WISH) at various developmental stages including 30, 36 and 52 hpf (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S1</uri>, <italic>kdrl</italic> and <italic>dll4</italic>). Consistent with the angiogenic defects revealed by <italic>Tg(kdrl:EGFP)</italic> transgenic animals, expression of <italic>kdrl</italic> and <italic>dll4</italic> in the vasculature of the hindbrain was reduced in <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos at all stages examined (red arrows in <uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S1</uri>, <italic>kdrl</italic> and <italic>dll4</italic>). These vascular defects in mutants appeared not to be due to gross defects of brain development because the expression of <italic>krox20</italic>, which marks rhombomere boundaries (<xref ref-type="bibr" rid="DMM037044C57">Moens and Prince, 2002</xref>; <xref ref-type="bibr" rid="DMM037044C61">Oxtoby and Jowett, 1993</xref>), and <italic>isl1</italic>, which labels primary motoneurons in the hindbrain (<xref ref-type="bibr" rid="DMM037044C19">Ericson et al., 1992</xref>; <xref ref-type="bibr" rid="DMM037044C38">Inoue et al., 1994</xref>; <xref ref-type="bibr" rid="DMM037044C45">Korzh et al., 1993</xref>), were grossly unaffected in mutant embryos (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S1</uri>, <italic>krox20</italic> and <italic>isl1</italic>). These vascular defects appeared not to be due to defective heart development or reduced blood flow, based on the normal heartrate of mutants compared to the WT embryos (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S2</uri>, <uri xlink:href="http://movie.biologists.com/video/10.1242/dmm.037044/video-1">Movies 1</uri> and <uri xlink:href="http://movie.biologists.com/video/10.1242/dmm.037044/video-2">2</uri>).</p>
</sec>
<sec id="s2b">
<title>Zebrafish <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic>, mammalian <italic>DYRK1A</italic> orthologs, are expressed in endothelial cells and the nervous system during development</title>
<p>We examined transcripts of <italic>dyrk1aa</italic> in zebrafish embryos using WISH during embryogenesis. <italic>dyrk1aa</italic> mRNA had a broad expression in the forebrain (black arrowheads/brackets), midbrain (gray arrowheads/brackets), hindbrain (blue arrowheads/brackets), spinal cord (orange arrowheads), heart (asterisks) and retina (red arrows) at 24, 48 and 72 hpf (<xref ref-type="fig" rid="DMM037044F2">Fig. 2</xref>Aa-Al). Transverse sections of WISH embryos at the midbrain level showed that <italic>dyrk1aa</italic> was broadly expressed in the tectum (green arrows), tegmentum (black arrow), the ganglionic cell layer (purple arrows) and the inner nuclear layer of the retina (red arrows) (<xref ref-type="fig" rid="DMM037044F2">Fig. 2</xref>Am,An). We also checked the expression patterns of <italic>dyrk1ab</italic> mRNA (ZFIN ID: ZDB-GENE-030131-5677), another zebrafish ortholog of human <italic>DYRK1A</italic>, using WISH, which appeared to be significantly overlapped with those of <italic>dyrk1aa</italic> (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S3</uri>).
<fig id="DMM037044F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>Zebrafish <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> are expressed in the developing brain during embryogenesis and detected in endothelial cells of the vasculature.</bold> (A) WISH showed that <italic>dyrk1aa</italic> was expressed in the forebrain (black arrowheads, Aa-Af; black brackets, Ag-Al), the midbrain (gray arrowheads, Aa-Af; gray brackets, Ag-Al), the hindbrain (blue arrowheads, Aa-Af; blue brackets, Ag-Al) at 24, 48 and 72 hpf, and the spinal cord (orange arrowheads, Aa and Ab) at 24 hpf. It was also detected in the heart (black asterisks, Ad,Af,Aj,Al) and in the retina (red arrows, Ai-Al) at 48 and 72 hpf. Am and An are sectioned images of WISH embryos showing the expression of <italic>dyrk1aa</italic> in the tectum (green arrows), tegmentum (black arrow), the ganglionic cell layer (purple arrows) and the inner nuclear layer of the retina (red arrows) at 48 hpf and 72 hpf. See <uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S3</uri> for WISH of <italic>dyrk1ab</italic>. (B) Semi-quantitative RT-PCR analysis of <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> mRNA expression in whole embryos at indicated developmental stages. <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> expression was observed at the one-cell stage followed by diminishing at 6 hpf and resuming after 24 hpf. (C) Semi-quantitative RT-PCR analysis using endothelial cells isolated by FACS for sorting GFP-positive and -negative cells of <italic>Tg(kdrl:EGFP)</italic> embryos at 48 hpf revealed that <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> mRNAs were expressed in GFP-positive endothelial cells as well as in GFP-negative embryonic cells. Scale bars: 200 µm in Aa-Al; 50 µm in Am,An.</p></caption><graphic xlink:href="dmm-12-037044-g2"></graphic></fig></p>
<p>The temporal expression patterns of <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> mRNAs according to developmental stages by reverse transcription-PCR (RT-PCR) were also examined. Transcripts of <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> mRNA were strongly detectable at the one-cell stage but decreased after 6 hpf, presumably because of the maternal effect (<xref ref-type="bibr" rid="DMM037044C31">Harvey et al., 2013</xref>; <xref ref-type="bibr" rid="DMM037044C54">Mathavan et al., 2005</xref>) (<xref ref-type="fig" rid="DMM037044F2">Fig. 2</xref>B). Zygotic <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> expression appeared to start at ∼15 hpf, increasing at 24 hpf, and strong expression was maintained until 5 days postfertilization (dpf) (<xref ref-type="fig" rid="DMM037044F2">Fig. 2</xref>B).</p>
<p>Furthermore, whether <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> mRNA was specifically expressed in endothelial cells was confirmed by performing RT-PCR analyses using GFP-positive <italic>Tg(kdrl:EGFP)</italic> endothelial cells isolated by fluorescence-activated cell sorting (FACS). The <italic>dyrk1aa</italic> and <italic>dyrk1ab</italic> mRNA was enriched in GFP-positive endothelial cells but was also expressed in GFP-negative cells, suggesting a role in endothelial as well as non-endothelial cells (<xref ref-type="fig" rid="DMM037044F2">Fig. 2</xref>C). These expression patterns were consistent with the reported mammalian <italic>Dyrk1a</italic> expression in the heart primordium and the central nervous system of developing mouse embryos, including the inner (neural) layer of the optic cup (<xref ref-type="bibr" rid="DMM037044C30">Hämmerle et al., 2008</xref>; <xref ref-type="bibr" rid="DMM037044C66">Rahmani et al., 1998</xref>), and endothelial cells isolated from <italic>Dscr1</italic> transgenic mice, as assessed using western blotting (<xref ref-type="bibr" rid="DMM037044C3">Baek et al., 2009</xref>), suggesting a functional conservation across species. Recently, the expression of DYRK1A at the protein and RNA level in human endothelial cells and in mouse lung endothelial cells has also been shown by <xref ref-type="bibr" rid="DMM037044C70">Rozen et al. (2018)</xref>.</p>
</sec>
<sec id="s2c">
<title>Rescuing <italic>dyrk1aa<sup>krb1</sup></italic> mutant phenotypes by <italic>dyrk1aa</italic> expression</title>
<p>To confirm that loss of function of the <italic>dyrk1aa</italic> gene was responsible for <italic>dyrk1aa<sup>krb1</sup></italic> mutant phenotypes, we tested whether WT <italic>dyrk1aa</italic> mRNA rescued the cerebral hemorrhage and aberrant vascular phenotype in <italic>dyrk1aa<sup>krb1</sup></italic> mutants by globally expressing full-length WT <italic>dyrk1aa</italic> mRNA. Using <italic>o</italic>-dianisidine staining, the high incidence of cerebral hemorrhage in <italic>dyrk1aa<sup>krb1</sup></italic> mutants under heat stress (41.7% of the offspring) was shown to be significantly reduced down to 25.4% by 0.1 ng <italic>dyrk1aa</italic> mRNA injection (<xref ref-type="fig" rid="DMM037044F3">Fig. 3</xref>A,B), whereas the same dose injected into the WT background had little effect (<xref ref-type="fig" rid="DMM037044F3">Fig. 3</xref>A,C). Similarly, the reduced mean percentages of lengths (66.5%) and branching points (61.2%) of CtAs in <italic>dyrk1aa<sup>krb1</sup></italic> mutants relative to WT controls (100%) were rescued (89.9% and 122%, respectively) with the expression of 0.1 ng <italic>dyrk1aa</italic> mRNA (<xref ref-type="fig" rid="DMM037044F3">Fig. 3</xref>D,E). The rescue of CtA angiogenesis defects were effective only within specific dose ranges of <italic>dyrk1aa</italic> mRNA expression in <italic>dyrk1aa<sup>krb1</sup></italic> mutants, and overexpression of <italic>dyrk1aa</italic> mRNA in WT background increased CtA formation in a dose-dependent manner (<xref ref-type="fig" rid="DMM037044F3">Fig. 3</xref>E), suggesting the importance of spatial and temporal contexts for effects of <italic>dyrk1aa</italic> expression as well as its dose-sensitive nature.
<fig id="DMM037044F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>The cerebral hemorrhage and CtA angiogenic defects in <italic>dyrk1aa<sup>krb1</sup></italic> mutants can be rescued by <italic>dyrk1aa</italic> expression, with the kinase activity of Dyrk1aa required for its phenotypic rescues.</bold> (A) The <italic>o</italic>-dianisidine staining images at 52 hpf showed that the cerebral hemorrhage (arrows) of <italic>dyrk1aa<sup>krb1</sup></italic> embryos was rescued by WT <italic>dyrk1aa</italic> mRNA expression, but not in no-injection control, <italic>K193R-dyrk1aa</italic> or <italic>mCherryRed</italic> mRNA. (B) The frequency of cerebral hemorrhage of <italic>dyrk1aa<sup>krb1</sup></italic> was reduced from 41.7% to 25.4% by injecting WT <italic>dyrk1aa</italic> mRNA of 0.1 ng, but not significantly changed by injecting <italic>K193R-dyrk1aa</italic> or <italic>mCherryRed</italic> mRNA at 52 hpf. (C) Injection of mRNAs of WT <italic>dyrk1aa</italic>, <italic>K193R-dyrk1aa</italic> or <italic>mCherryRed</italic> control did not affect the cerebral hemorrhage in WT embryos at 52 hpf. The mean percentages for each genotype were presented from three independent experiments with approximately 20 embryos in each repeat. (D) The compiled images of CtAs of <italic>Tg(kdrl:EGFP)</italic> at 52 hpf by confocal microscopy showed that the angiogenic defects of the CtAs of <italic>dyrk1aa<sup>krb1</sup></italic> embryos were rescued by WT <italic>dyrk1aa</italic> mRNA injection. (E) The mean percentages of length and branching points of CtAs in <italic>dyrk1aa<sup>krb1</sup></italic> mutants were rescued from 66.5% to 83.4% and from 61.2% to 108.3%, respectively, with 0.05 ng of <italic>dyrk1aa</italic> mRNA injection, relative to WT as 100%, and rescued to 89.9% and 122.0%, respectively, with 0.1 ng of <italic>dyrk1aa</italic> mRNA injection. Expression with 0.2 ng of <italic>dyrk1aa</italic> mRNA did not exhibit the rescue effect. Expression of <italic>dyrk1aa</italic> mRNA with the same doses in WT embryos also increased the length and branching points of CtAs in a dose-dependent manner (113.8% and 139.6% with 0.2 ng of <italic>dyrk1aa</italic> mRNA, respectively). *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.005 (one-way ANOVA). n.s., not significant. Data are mean±s.e.m. Scale bar: 100 µm in A; 50 µm in D.</p></caption><graphic xlink:href="dmm-12-037044-g3"></graphic></fig></p>
<p>DYRK1A regulates its target substrate proteins via phosphorylation (<xref ref-type="bibr" rid="DMM037044C29">Hämmerle et al., 2003</xref>). To verify whether the cerebral hemorrhage and CtA defects in <italic>dyrk1aa<sup>krb1</sup></italic> mutants were dependent on the kinase activity of Dyrk1aa, we performed rescue experiments with <italic>K193R-dyrk1aa</italic> mRNA, the predicted kinase-dead form of Dyrk1aa (<xref ref-type="bibr" rid="DMM037044C34">Himpel et al., 2001</xref>). The expression of <italic>K193R-dyrk1aa</italic> mRNA or control mCherryRed mRNA failed to rescue the defects of hemorrhage and CtA formation with comparable doses of WT-<italic>dyrk1aa</italic> mRNA (<xref ref-type="fig" rid="DMM037044F3">Fig. 3</xref>B; <uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S4A and S4B</uri>). These results suggest that the kinase activity of Dyrk1aa is critical for normal CtA development and prevention of hemorrhage.</p>
</sec>
<sec id="s2d">
<title>Ultrastructural analyses of cerebral vessels in <italic>dyrk1aa<sup>krb1</sup></italic> mutants by transmission electron microscopy</title>
<p>To examine whether the <italic>dyrk1aa</italic> mutation caused an ultrastructural change in brain vessels, we analyzed the cytoarchitecture of blood vessels in the WT and <italic>dyrk1aa<sup>krb1</sup></italic> embryos at 52 hpf using transmission electron microscopy. In the WT group, blood vessels composed of endothelial cells and lumens were well formed and tightly arranged at this stage (<xref ref-type="fig" rid="DMM037044F4">Fig. 4</xref>A,A′), although smooth muscle cells, pericytes and astrocytes were in the process of differentiation and not yet clearly identified (<xref ref-type="bibr" rid="DMM037044C47">Liu et al., 2007</xref>). Characteristically, brain tissues in <italic>dyrk1aa<sup>krb1</sup></italic> mutants exhibited enlarged interstitial spaces, presumably because of loose connections between layers of vessel walls (arrowheads in <xref ref-type="fig" rid="DMM037044F4">Fig. 4</xref>B,B′), suggesting that this abnormal formation of vessel walls was one of the causes of the hemorrhagic phenotype in <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos.
<fig id="DMM037044F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p><bold>The transmission electron microscopy revealed that <italic>dyrk1aa<sup>krb1</sup></italic> embryos had abnormal vessel walls in the brain at 52 hpf.</bold> (A,B) Brain vessels in WT and <italic>dyrk1aa<sup>krb1</sup></italic>. A′ and B′ show enlarged images of the boxed areas in A and B, respectively. (A′,B′) Arrows in A′ indicate the compact structure of vessel walls, whereas arrowheads in B′ designate the loose connection of vessel walls. Dashed lines demarcate the border between the vessel walls and the lumen. EC, endothelial cell; LM, vessel lumen; RBC, red blood cell; VW (dotted arrows), vessel wall. Scale bars: 1 µm.</p></caption><graphic xlink:href="dmm-12-037044-g4"></graphic></fig></p>
</sec>
<sec id="s2e">
<title>DYRK1A inhibition by harmine and chemical screening</title>
<p>Cerebral angiogenic defects and hemorrhage in <italic>dyrk1aa<sup>krb1</sup></italic> mutants were also recapitulated by harmine (7-methoxy-1-methyl-9H-pyrido[3,4-b]-indole), a well-known DYRK1A inhibitor (<xref ref-type="bibr" rid="DMM037044C4">Bain et al., 2007</xref>; <xref ref-type="bibr" rid="DMM037044C25">Göckler et al., 2009</xref>). WT zebrafish embryos exposed to different concentrations of harmine (10, 25 and 50 µM) starting at 24 hpf for 28 h showed the hemorrhage and CtA formation defects at 52 hpf, similar to those of the <italic>dyrk1aa<sup>krb1</sup></italic> mutants, and the number of CtA sprouts was reduced down to 15.2% of the control number at a concentration of 50 µM harmine (<xref ref-type="fig" rid="DMM037044F5">Fig. 5</xref>A,B). The harmine-induced hemorrhagic phenotype increased up to 65.7% that of the offspring, compared to 2.3% of the DMSO-treated controls (<xref ref-type="fig" rid="DMM037044F5">Fig. 5</xref>C). This chemical suppression of DYRK1A using harmine further suggested that the vascular phenotypes of <italic>dyrk1aa<sup>krb1</sup></italic> mutants were owing to the loss of DYRK1A function.
<fig id="DMM037044F5" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p><bold>Inhibition of DYRK1A by harmine induces brain hemorrhage and vasculature defects in the hindbrain.</bold> (A) WT <italic>Tg(kdrl:EGFP)</italic> embryos were treated with increasing concentrations of DYRK1A inhibitor harmine, from 24 hpf until 52 hpf: Aa, DMSO; Ab, 10 µM harmine; Ac, 25 µM harmine; Ad, 50 µM harmine. Vascular patterning defects of CtAs are shown (red brackets) by confocal imaging at 52 hpf (lateral view). (B) Quantification of the effect on number of developing CtAs by harmine treatment. The numbers of CtAs were dramatically reduced by treating harmine in a dose-dependent manner. <italic>n</italic>=11 each group. (C) Quantification of the brain hemorrhage penetrance. The cerebral hemorrhagic phenotype of 2.3% in DMSO-treated embryos was increased from 14.8% to 65.7% by harmine treatment from 10 µM to 50 µM. The mean percentage for each treatment was shown from three independent experiments with approximately 40 embryos in each repeat. (D) Schematic showing the strategy of the <italic>in vivo</italic> chemical library screening to identify small molecule modifiers for cerebral hemorrhagic phenotype upon DYRK1A inhibition. Data are mean±s.e.m. Scale bar: 100 µm.</p></caption><graphic xlink:href="dmm-12-037044-g5"></graphic></fig></p>
<p>Based on the hemorrhagic phenotype induced by harmine treatment, we developed an embryonic screening assay using a chemical library that consisted of 1280 FDA-approved and pharmacologically active compounds (LOPAC 1280; Sigma-Aldrich), which allowed us to identify small molecules that modulated the harmine-induced hemorrhagic phenotype. Five WT zebrafish embryos at 24 hpf were placed in each well of a 48-well plate, exposed to 30 µM harmine together with the individual chemicals of the chemical library at 10 µM as a final concentration for 28 h, and analyzed for the increased or decreased hemorrhagic phenotype (<xref ref-type="fig" rid="DMM037044F5">Fig. 5</xref>D). As a result, 171 of 1280 compounds tested were found to be phenotype modifiers, which were categorized according to their common features as ‘class’ based on their known functions (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Tables S1-S3</uri>). Some chemicals have already been reported to cause hemorrhage. For example, atorvastatin, which increased the hemorrhage in our screening, has been previously reported to induce hemorrhagic stroke as a side effect in zebrafish embryos (<xref ref-type="bibr" rid="DMM037044C24">Gjini et al., 2011</xref>). Of the 171 compounds, EGTA, a specific calcium chelator, was identified as one of the most efficient suppressors of the hemorrhagic phenotype induced by harmine treatment, in our chemical screening.</p>
</sec>
<sec id="s2f">
<title>EGTA effectively suppressed the vascular defects of <italic>dyrk1aa<sup>krb1</sup></italic> mutants</title>
<p>To determine whether our findings from the chemical screening were applicable to the genetic model, we added EGTA to the <italic>dyrk1aa<sup>krb1</sup></italic> mutants and examined the hemorrhagic and CtA development. Under heat-stressed conditions, the EGTA treatment significantly reduced the hemorrhagic phenotype of <italic>dyrk1aa<sup>krb1</sup></italic> mutants at a specific concentration of 10 nM (from 37.5% to 23.6%, <xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>A,B; <italic>P</italic>&lt;0.05). In addition, a reduced CtA development of mutants in lengths and branching points (76% and 57.4% reduction compared to WT, respectively) was also rescued up to 86.6% and 85.9% of the normal levels, respectively, by treatment with the same concentrations of EGTA (<xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>C,D; <italic>P</italic>&lt;0.01). EGTA treatment appeared to be effective only within a narrow range, because 1 nM or 100 nM EGTA treatment failed to rescue the vascular defects of <italic>dyrk1aa<sup>krb1</sup></italic> mutants, except for the rescue of CtA branching points with 1 nM EGTA (<xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>B,D). In contrast, EGTA treatment of the WT embryos did not induce any vascular defects (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S5</uri>), suggesting a specific role of EGTA on <italic>dyrk1aa<sup>krb1</sup></italic> mutants.
<fig id="DMM037044F6" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p><bold>EGTA identified by the chemical library screening effectively rescues the cerebral hemorrhage and abnormal CtA development of <italic>dyrk1aa<sup>krb1</sup></italic> mutants.</bold> (A) <italic>o</italic>-dianisidine staining images at 52 hpf showing that the cerebral hemorrhage (arrow) of <italic>dyrk1aa<sup>krb1</sup></italic> embryos were rescued by treating with 10 nM EGTA. WT embryos were not affected by the treatment at the same concentration. (B) Quantitation of the rescue of the cerebral hemorrhagic phenotype by EGTA. The cerebral hemorrhage in <italic>dyrk1aa<sup>krb1</sup></italic> embryos is reduced from 37.5% to 23.6% by 10 nM EGTA treatment. The data is presented with five independent experiments with approximately 20 embryos in each repeat. (C) Compiled confocal microscopy images of the rescue effect on angiogenic defects of CtAs in <italic>dyrk1aa<sup>krb1</sup></italic> embryos by EGTA treatment. (D) Quantitative data showing that the reduced mean percentages of length and branching points of CtAs in <italic>dyrk1aa<sup>krb1</sup></italic> embryos at 52 hpf (76% and 57.4%, respectively, compared to WT embryos as 100%) were increased up to 86.6% and 85.9%, respectively, by 10 nM EGTA treatment. <italic>n</italic>≥11 each group. (E) Schematic depicts the treatment scheme of EGTA at developmental stages from 24 to 52 hpf in <italic>dyrk1aa<sup>krb1</sup></italic> embryos. (F) The cerebral hemorrhage of <italic>dyrk1aa<sup>krb1</sup></italic> embryos at 52 hpf (arrows) were rescued by 10 nM EGTA treatment for 24-32 hpf but not by the treatment for 32-48 hpf. (G) Quantitative data showing that cerebral hemorrhage of <italic>dyrk1aa<sup>krb1</sup></italic> embryos reduced from 37.7% to 26.3% by treating with 10 nM EGTA for 24-32 hpf. *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.005 (one-way ANOVA). n.s., not significant. Data are mean±s.e.m. Scale bars: 100 µm in A,F; 50 µm in C.</p></caption><graphic xlink:href="dmm-12-037044-g6"></graphic></fig></p>
<p>To identify the temporal requirement of EGTA for the suppressive effects, developing embryos were incubated with various doses of EGTA during an early period of 8 h (24∼32 hpf), followed by washing, or during a late period of 16 h (32∼48 hpf) (<xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>E). Interestingly, only the early treatment with 10 nM EGTA was effective in significantly preventing the cerebral hemorrhage (from 37.7% to 26.3%), whereas the early treatment with other doses and the late treatment was not (<xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>F,G). Because sprouting and elongation of cerebral vessels for angiogenesis occurs actively during day 1 postfertilization (<xref ref-type="bibr" rid="DMM037044C22">Fujita et al., 2011</xref>; <xref ref-type="bibr" rid="DMM037044C40">Isogai et al., 2001</xref>), EGTA may exert its suppressive effects on the vascular defects of <italic>dyrk1aa<sup>krb1</sup></italic> mutants by regulating early angiogenic processes.</p>
</sec>
<sec id="s2g">
<title>Transcriptomic analyses of <italic>dyrk1aa<sup>krb1</sup></italic> mutants</title>
<p>Identification of EGTA as a suppressor of vascular defects in <italic>dyrk1aa<sup>krb1</sup></italic> mutants by chemical screening implies that calcium signaling may be compromised in the <italic>dyrk1aa<sup>krb1</sup></italic> mutants. To corroborate this finding, we examined transcriptomic changes of <italic>dyrk1aa<sup>krb1</sup></italic> mutants compared to WT embryos at 48 hpf using RNA-seq analysis (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>). This analysis identified 222 transcripts as differentially regulated genes (DEG), of which 101 were upregulated and 121 were downregulated in the <italic>dyrk1aa<sup>krb1</sup></italic> mutants (more than 2-fold and less than 0.5-fold, respectively; <italic>P</italic>&lt;0.05). When DEGs were analyzed for enriched biological gene ontology (GO) categories by the functional annotation tools in the Database for Annotation, Visualization and Integrated Discovery (DAVID; <uri xlink:href="https://david.ncifcrf.gov">https://david.ncifcrf.gov</uri>), the calcium ion binding category was the most enriched GO molecular function (MF) (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>B). This GO category includes genes encoding several calcium-dependent adhesion proteins, protocadherin (Pcdh) family members (<italic>pcdh1g1</italic>, <italic>pcdh2ab10</italic>, <italic>pcdh1gc6</italic>, <italic>pcdh2g17</italic>, <italic>pcdh1g18</italic> and <italic>pcdh1g30</italic>) and calcium-dependent calpains (<italic>capn8</italic> and <italic>capn2l</italic>) (<xref ref-type="bibr" rid="DMM037044C43">Khorchid and Ikura, 2002</xref>) (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>A). Other genes encoding myosin light chain 4 (<italic>myl4</italic>), low-density lipoprotein receptor b (<italic>ldlrb</italic>), and mannan-binding lectin serine protease 2 (<italic>masp2</italic>) in this GO term are also regulated by calcium signaling, directly or indirectly (<xref ref-type="bibr" rid="DMM037044C42">Kang et al., 1999</xref>; <xref ref-type="bibr" rid="DMM037044C60">Orr et al., 2016</xref>; <xref ref-type="bibr" rid="DMM037044C88">Zhao and Michaely, 2009</xref>) (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>A), although their roles in regulating vascular formation are not understood at present. In addition, the ‘oxidation-reduction process’, the top-ranked GO biological process (BP), is also well known to affect calcium signaling networks (<xref ref-type="bibr" rid="DMM037044C26">Görlach et al., 2015</xref>; <xref ref-type="bibr" rid="DMM037044C50">Lounsbury et al., 2000</xref>) (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>C), and the genes belonging to the ‘homophilic cell adhesion via plasma membrane adhesion molecules’ BP category consist of the six Pcdh family genes ‘calcium ion binding’ MF category (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>C).
<fig id="DMM037044F7" orientation="portrait" position="float"><label>Fig. 7.</label><caption><p><bold>Whole transcriptomic analysis of <italic>dyrk1aa<sup>krb1</sup></italic> compared with WT using RNA-seq.</bold> (A) Volcano plot showing the comparison of the whole transcriptomes of the pools of ∼20 WT and <italic>dyrk1aa<sup>krb1</sup></italic> embryos, set at 48 hpf (two biological replicates for each group). The colored dots show the differentially upregulated (red) or downregulated (blue) genes in <italic>dyrk1aa<sup>krb1</sup></italic> embryos compared to WT embryos (more than 2-fold, <italic>P</italic>&lt;0.05). The colored dots with black circles indicate the upregulated (red dot with black circle) and downregulated (blue dot with black circle) genes in the group of ‘calcium ion binding’ (see text for details). (B) Bar graph showing the list of the groups of DEGs in the classification of the molecular functions. DEGs of the ‘calcium ion binding’ are most abundant. (C) Bar graph showing the list of the groups of DEGs in the classification of the biological process. DEGs of the ‘oxidation-reduction process’ are most abundant. Bar graph <italic>x</italic>-axis (B,C) represents the number of DEG counts in respective annotations.</p></caption><graphic xlink:href="dmm-12-037044-g7"></graphic></fig></p>
<p>We checked the validity of DEG identification by RNA-seq analysis with RT-PCR using RNAs from the whole embryos or from FACS-isolated endothelial cells at 48 hpf (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S6</uri>). As a result, nine out of 15 candidate DEGs (<italic>pcdh1g1</italic>, <italic>pcdh2ab10</italic>, <italic>pcdh1gc6</italic>, <italic>myl4</italic>, <italic>pcdh1g18</italic>, <italic>f7i</italic>, <italic>capn8</italic>, <italic>pcdh1g30</italic> and <italic>capn2l</italic>) were clearly changed in the whole <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S6A</uri>). Those nine DEGs were further tested for expression changes in endothelial cells by performing another RT-PCR using RNAs prepared from FACS-isolated endothelial cells of 48 hpf <italic>Tg(kdrl:EGFP)</italic> WT and <italic>dyrk1aa<sup>krb1</sup></italic> mutants. Seven DEGs (<italic>pcdh1g1</italic>, <italic>pcdh2ab10</italic>, <italic>myl4</italic>, <italic>pcdh1g18</italic>, <italic>f7i</italic>, <italic>pcdh1g30</italic> and <italic>capn2l</italic>) were found to be correlative with the similar patterns as in the whole embryos (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S6B</uri>), suggesting their potential roles in <italic>dyrk1aa</italic>-mediated calcium signaling in endothelial cells.</p>
<p>In order to check whether calcium signaling changes occur even earlier than 48 hpf, especially when rescue by EGTA treatment is effective (<xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>), we also investigated the transcriptomic changes in <italic>dyrk1aa<sup>krb1</sup></italic> mutants at 32 hpf using RNA-seq analysis (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S7</uri>). Similar to the findings of 48 hpf transcriptomic analysis, DEGs at 32 hpf were already highly enriched in the GO categories of ‘calcium ion binding’ and ‘oxidoreductase activity’ in MF (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S7A,B</uri>). Furthermore, expression of six genes in the calcium ion binding category (<italic>pcdh1g1</italic>, <italic>pcdh1g18</italic>, <italic>f7i</italic>, <italic>capn8</italic>, <italic>pcdh1g30</italic> and <italic>capn2l</italic>) turned out to be concurrently changed in both 32 hpf and 48 hpf transcriptomes (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S7C</uri>). Interestingly, five genes (<italic>pcdh1g1</italic>, <italic>pcdh1g18</italic>, <italic>f7i</italic>, <italic>pcdh1g30</italic> and <italic>capn2l</italic>) out of these six DEGs were also changed in the FACS-isolated endothelial cells (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S6B</uri>), potentially highlighting their indispensability in <italic>dyrk1aa</italic>-mediated calcium signaling.</p>
<p>Collectively, alterations of genes in ‘calcium ion binding’ and other GO categories may reflect dysregulation of calcium homeostasis in <italic>dyrk1aa<sup>krb1</sup></italic> mutants, consistent with the rescue effects by EGTA on vascular defects of mutants.</p>
</sec>
<sec id="s2h">
<title>Modulation of intracellular calcium signaling also rescued vascular defects of <italic>dyrk1aa<sup>krb1</sup></italic> mutants</title>
<p>As noted previously, EGTA is a chelating agent that has strong selectivity for calcium ions, primarily by lowering the level of extracellular calcium, eventually affecting the calcium homeostasis inside a cell, which is an essential process for regulating angiogenesis as well as other cellular processes including muscle contraction and neurogenesis (<xref ref-type="bibr" rid="DMM037044C6">Berridge et al., 2000</xref>; <xref ref-type="bibr" rid="DMM037044C58">Munaron, 2006</xref>). To assess whether the modulation of intracellular calcium signaling can recapitulate the effects of EGTA treatment, we attempted to rescue the cerebral hemorrhage and defective CtA formation of <italic>dyrk1aa<sup>krb1</sup></italic> mutants by inhibiting calcineurin protein with FK506, a well-known specific calcineurin inhibitor (<xref ref-type="bibr" rid="DMM037044C46">Li et al., 2011</xref>). The signaling pathway mediated by calcineurin, a serine/threonine protein phosphatase, is one of the major signaling pathways that is regulated by calcium (<xref ref-type="bibr" rid="DMM037044C12">Crabtree, 2001</xref>; <xref ref-type="bibr" rid="DMM037044C36">Hogan et al., 2003</xref>). Interestingly, the hemorrhagic phenotype of <italic>dyrk1aa<sup>krb1</sup></italic> was rescued by treatment with 50 and 100 ng/ml FK506 in a dose-dependent manner, whereas no significant change was observed in the WT control when treated (<xref ref-type="fig" rid="DMM037044F8">Fig. 8</xref>A,B). The same concentrations of FK506 also rescued defects in the CtA branching points (100 ng/ml) and length (50 ng/ml) of mutants, although FK506 also increased those of CtAs in the WT control (<xref ref-type="fig" rid="DMM037044F8">Fig. 8</xref>C,D). These data were consistent with the notion that the dysregulation of calcium homeostasis was responsible for the vascular defects of the <italic>dyrk1aa<sup>krb1</sup></italic> mutants, and such defects could be rescued, at least partially, by manipulating a calcium-dependent signaling pathway.
<fig id="DMM037044F8" orientation="portrait" position="float"><label>Fig. 8.</label><caption><p><bold>FK506 rescues the cerebral hemorrhage and CtA angiogenic defects in <italic>dyrk1aa<sup>krb1</sup></italic> mutants.</bold> (A) The cerebral hemorrhage of <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos (arrows) was rescued by the treatment of 50 ng/ml FK506. (B) The cerebral hemorrhage in <italic>dyrk1aa<sup>krb1</sup></italic> mutant embryos at 52 hpf (40.5%) was reduced to 17.8% and 13.4% by the treatment of 50 ng/ml and 100 ng/ml FK506, respectively. No differences were seen in WT with the same treatments. (C) The compiled confocal microscopy images of CtAs in the <italic>Tg</italic>(<italic>kdrl:EGFP</italic>) background showed that CtA defects in <italic>dyrk1aa<sup>krb1</sup></italic> embryos were rescued by FK506 treatment in a dose-dependent manner, and CtA angiogenesis in WT was also affected. (D) The reduced mean percentage of CtA length of <italic>dyrk1aa<sup>krb1</sup></italic> mutants (75.5%) was significantly rescued up to 84.6% by 50 ng/ml FK506, whereas that of mutant branching points (74.3%) was significantly rescued up to 96.4% by 100 ng/ml FK506 at 52 hpf, compared to WT embryos as 100%. 50 ng/ml FK506 treatment increased the WT CtA length up to 110.3%, whereas 100 ng/ml FK506 treatment increased both length and branching points of WT CtAs (109.5% and 133.8%, respectively). *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.005 (one-way ANOVA). n.s., not significant. Data are mean±s.e.m. Scale bars: 100 µm in A; 50 µm in C.</p></caption><graphic xlink:href="dmm-12-037044-g8"></graphic></fig></p>
<p>Modulation of calcium signaling by EGTA or FK506, however, did not reverse the transcriptional changes of DEGs found in transcriptomic analysis of <italic>dyrk1aa<sup>krb1</sup></italic> mutants (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S8</uri>), implying that they may not be appropriate readouts for the phenotypic reversal. In addition, expression of potential zebrafish homologs of <italic>RCAN1.4</italic>, a known target gene in Dyrk1a/Calcineurin pathway (<xref ref-type="bibr" rid="DMM037044C55">Minami et al., 2004</xref>; <xref ref-type="bibr" rid="DMM037044C70">Rozen et al., 2018</xref>), was not changed in <italic>dyrk1aa<sup>krb1</sup></italic> mutants (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Fig. S9</uri>). These additional data suggest an involvement of more complex mechanisms <italic>in vivo</italic> with regard to calcium signaling regulated by <italic>dyrk1aa</italic>.</p>
</sec>
</sec>
<sec id="s3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Proper cerebrovascular development and maintenance are essential processes for normal brain development and function, and are governed by diverse and coordinated signaling pathways (<xref ref-type="bibr" rid="DMM037044C35">Hogan and Schulte-Merker, 2017</xref>). In this report, we established a less-known function of <italic>DYRK1A</italic>, one of the critical genes contributing to some DS phenotypes, in regulating angiogenesis and preventing hemorrhage in the brain, using zebrafish <italic>dyrk1aa</italic> knockout mutants. The <italic>in vivo</italic> chemical screening using zebrafish embryos identified small molecules that were able to modify the cerebral hemorrhage upon DYRK1A inhibition. Among them, EGTA, a known specific calcium chelator, was identified as one of the most effective small molecules that rescued the vascular defects of <italic>dyrk1aa</italic> mutants. Changes in calcium-related signaling pathways revealed by RNA-seq analyses and the rescuing activity by chemical inhibition of calcineurin, a major component of the calcium-dependent pathway, on the vascular defects corroborated the notion that the vascular defects of <italic>dyrk1aa</italic> mutants were primarily due to calcium dysregulation, which could be reversed by inhibition of excessive calcium-dependent processes.</p>
<p>Zebrafish <italic>dyrk1aa</italic> knockout mutants exhibited compromised vessel integrity, with cerebral hemorrhage and angiogenesis simultaneously (<xref ref-type="fig" rid="DMM037044F1">Figs 1</xref> and <xref ref-type="fig" rid="DMM037044F4">4</xref>), compared to WT controls. Although the relationship between angiogenesis, vessel permeability and cerebral hemorrhage during developmental processes is not clearly defined, the interactions of these processes may be important for development of the functional cerebral vasculature. For example, a targeted deletion of miR-126 in mice showed that the cerebral hemorrhage due to defective vascular integrity accompanied a severe reduction in cranial vessel formation (<xref ref-type="bibr" rid="DMM037044C85">Wang et al., 2008</xref>). In addition, excessive angiogenesis was shown to precede the cerebral hemorrhage in the developing brain of neuroendothelium-specific <italic>Itgb8</italic> knockout mice (<xref ref-type="bibr" rid="DMM037044C2">Arnold et al., 2014</xref>). Based on the mutant phenotypes described in our report, it is possible that DYRK1A may be a novel dual-function player that regulates both cerebral angiogenesis and the maintenance of vascular integrity simultaneously to prevent hemorrhage in the developing brain. Consistent with this idea, it has been reported that DS fetuses displayed several developmental vascular defects revealed by ultrasound scanning (<xref ref-type="bibr" rid="DMM037044C9">Chaoui, 2005</xref>), whereas DS adults suffered a significantly higher risk of hemorrhagic stroke, as shown in a large cohort study (<xref ref-type="bibr" rid="DMM037044C74">Sobey et al., 2015</xref>), suggesting potential dual roles of <italic>DYRK1A</italic> in these vascular disorders.</p>
<p><italic>DYRK1A</italic> function in angiogenesis and hemorrhage prevention is likely to be a calcium-dependent process, based on the comparative transcriptome analyses of the WT and <italic>dyrk1aa</italic> mutants (<xref ref-type="fig" rid="DMM037044F7">Fig. 7</xref>). The DEG analysis identified ‘calcium ion binding’ as the top-ranked GO category, which may reflect dysregulation of calcium homeostasis in <italic>dyrk1aa</italic> mutants. Of interest, several genes in the ‘calcium ion binding’ category have been associated with endothelial cell permeability and vascular dysfunction. For example, protocadherin genes such as the Pcdh-gamma cluster, one of the prominent groups of DEGs from our analysis, were recently reported to be highly expressed in endothelial cells of the brain microvasculature and may contribute to junctional stability of the blood-brain barrier (<xref ref-type="bibr" rid="DMM037044C16">Dilling et al., 2017</xref>). Altered DEGs in the ‘oxidoreductase activity’ MF category and ‘oxidation-reduction process’ BP category in <italic>dyrk1aa</italic> mutants are also consistent with the disruption of Ca<sup>2+</sup> signaling, because redox homeostasis is one of the major factors in regulating intracellular Ca<sup>2+</sup> signaling events as well as vascular development (<xref ref-type="bibr" rid="DMM037044C50">Lounsbury et al., 2000</xref>).</p>
<p>The calcium signal-related function of DYRK1A in cerebrovascular formation and maintenance is also supported by results from the <italic>in vivo</italic> chemical screening and calcineurin inhibition studies. The specific calcium chelator EGTA was identified as one of the most potent small molecules that rescued the cerebral hemorrhage elicited by DYRK1A inhibition (<xref ref-type="fig" rid="DMM037044F6">Fig. 6</xref>). The Ca<sup>2+</sup> ion level inside the cytosol is normally maintained at a low concentration (approximately 100 nM), compared to a significantly higher (more than 20,000-fold) concentration in the extracellular environment (<xref ref-type="bibr" rid="DMM037044C10">Clapham, 2007</xref>), illustrating the importance of the tight regulation of calcium homeostasis across the membrane in maintaining normal cellular functions. As EGTA is an extracellular calcium chelator, it may affect the calcium function either extracellularly by directly attenuating the activities of calcium-dependent extracellular vascular ligands and cell adhesion molecules (<xref ref-type="bibr" rid="DMM037044C15">Deli, 2009</xref>; <xref ref-type="bibr" rid="DMM037044C81">Tomita et al., 1996</xref>), or intracellularly by lowering the amount of calcium entry into the cells. Our data suggested that both scenarios would be possible based on the facts that cerebral vessels in the mutants were disrupted at the ultrastructural level, presumably because of the altered calcium-dependent vascular integrity (<xref ref-type="fig" rid="DMM037044F4">Fig. 4</xref>), and rescue of the mutants' vascular phenotypes were mimicked by inhibiting a calcium-dependent intracellular signaling pathway using FK506, a specific calcineurin inhibitor (<xref ref-type="fig" rid="DMM037044F8">Fig. 8</xref>). Consistent with these findings, dantrolene, a RyR antagonist that decreases the intracellular calcium level (<xref ref-type="bibr" rid="DMM037044C21">Fruen et al., 1997</xref>), was also identified as a modestly effective small molecule in our chemical screening, although it did not reach statistical significance in our detailed analyses (<uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Table S3</uri> and data not shown).</p>
<p>An underlying mechanism by which DYRK1A regulates the calcium signaling in vascular formation is not yet clear. DYRK1A may affect Ca<sup>2+</sup> flux directly, as in the case of GluN2A-containing N-methyl-D-aspartate glutamate receptor phosphorylation by DYRK1A, leading to the elevation of their density on the membrane, and eventually to neurological dysfunction (<xref ref-type="bibr" rid="DMM037044C28">Grau et al., 2014</xref>). Alternatively, DYRK1A may indirectly influence Ca<sup>2+</sup> signaling by phosphorylating mediators that determine the expression or activity of calcium-dependent effectors, similar to myocardial pathology, in which phosphorylation of alternative splicing factor by DYRK1A increases the expression of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II δ (<xref ref-type="bibr" rid="DMM037044C33">He et al., 2015</xref>). Because DYRK1A is likely to be functional both in the nucleus and in the cytoplasm, based on its ubiquitous localization at the cellular level (<xref ref-type="bibr" rid="DMM037044C53">Marti et al., 2003</xref>), it may directly or indirectly regulate membrane-bound ion channels near the cell membrane (similar to GluN2A phosphorylation), intracellular signaling molecules in the cytoplasm or transcription factors in the nucleus, eventually maintaining the Ca<sup>2+</sup> homeostasis of cells.</p>
<p>Together, our characterization of zebrafish <italic>dyrk1aa</italic> knockout mutants showed that <italic>DYRK1A</italic> is implicated in cerebral angiogenic activity and the maintenance of vascular integrity during development. The combination of detailed transcriptomic analyses and chemical screening results strongly suggested that the calcium-dependent signaling regulated by <italic>DYRK1A</italic> is one of the major signaling pathways responsible for such vascular phenotypes. However, detailed signaling molecules and pathways affected in <italic>dyrk1aa</italic> mutants remain to be further studied. Our results also illustrate the usefulness of zebrafish <italic>dyrk1aa</italic> mutants in providing an <italic>in vivo</italic> animal model to understand the pathophysiology of human vascular diseases related to <italic>DYRK1A</italic> function and in suggesting potential therapeutic approaches for effective treatments.</p>
</sec>
<sec id="s4" sec-type="methods">
<title>MATERIALS AND METHODS</title>
<sec id="s4a">
<title>Maintaining zebrafish embryos</title>
<p>Zebrafish (<italic>Danio rerio</italic>) embryos of AB (WT) strain, transgenic zebrafish <italic>Tg(kdrl:EGFP)</italic> and <italic>dyrk1aa</italic> knockout mutant zebrafish (<italic>dyrk1aa<sup>krb1</sup></italic>) were maintained in E3 egg water (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl<sub>2</sub>, 0.33 mM MgSO<sub>4</sub>) in a petri dish at 28.5°C. In order to generate transparent zebrafish embryos for imaging confocal microscopy, performing WISH and examining hemorrhagic phenotype, embryos were incubated in 1× PTU (0.003% 1-phenyl 2-thiourea, Sigma-Aldrich)-E3 egg water after 6 hpf. Zebrafish husbandry and animal care were performed in accordance with guidelines from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) and approved by KRIBB-IACUC (approval number: KRIBB-AEC-17126).</p>
</sec>
<sec id="s4b">
<title><italic>o</italic>-Dianisidine staining and quantification of the hemorrhagic phenotype</title>
<p>Embryos at 52 hpf were fixed with 4% paraformaldehyde in 1× phosphate-buffered saline (PBS) for 4 h at room temperature (RT) and washed with 1× PBS containing 0.1% Tween 20 (1× PBST). The embryos were placed in <italic>o</italic>-dianisidine stain solution [0.6 mg/ml <italic>o</italic>-dianisidine (Sigma-Aldrich), 0.01 M sodium acetate (pH 5.5), 0.65% hydrogen peroxide and 40% ethanol] in the dark for several minutes at RT to detect hemoglobin activity. <italic>o</italic>-Dianisidine is a peroxidase substrate, and hemoglobin catalyzes the H<sub>2</sub>O<sub>2</sub>-mediated oxidation of <italic>o</italic>-dianisidine. Stained embryos were washed several times with 1× PBST and stored in 70% glycerol for imaging using an Olympus SZX16 microscope equipped with TUCSEN Dhyana 400DC camera. The cerebral hemorrhagic phenotype was calculated as the mean percentages by counting the number of embryos with hemorrhagic phenotype in the brain and the retina.</p>
</sec>
<sec id="s4c">
<title>FACS analysis of endothelial cells</title>
<p>To isolate GFP-positive endothelial cells from <italic>Tg(kdrl:EGFP)</italic> embryos, we adopted the protocol developed by <xref ref-type="bibr" rid="DMM037044C52">Manoli and Driever (2012)</xref>. Briefly, 150 embryos at 48 hpf were dechorionated with 1 mg/ml protease (P6911, Sigma-Aldrich) in E3 egg water for 5 min at RT, and washed in 0.5× Danieau's solution [29 mM NaCl, 0.35 mM KCl, 0.2 mM MgSO<sub>4</sub>•7H<sub>2</sub>O, 0.3 mM Ca(NO<sub>3</sub>)<sub>2</sub>, 2.5 mM HEPES (pH 7.6)]. The yolks of those embryos were removed using the deyolking buffer (55 mM NaCl, 1.8 mM KCl, 1.25 mM NaHCO<sub>3</sub>), followed by washing in 0.5× Danieau's solution, and embryonic cells were dissociated using FACS max cell dissociation solution (T200100, AMS Biotechnology) and the cell suspension passed through a 40 µm strainer (93040, SPL). FACS was performed at RT under sterile conditions using a FACSAria or FACSAria-Fusion (BD Biosciences).</p>
</sec>
<sec id="s4d">
<title>RNA preparation and RT-PCR analysis</title>
<p>Zebrafish embryos in each developmental stage or cells isolated by FACS were harvested with TRI reagent solution (Ambion), followed by purifying total RNA with Direct-zol RNA miniprep kit (Zymo Research) and synthesizing cDNA with SuperScript III First-Strand Synthesis System (Invitrogen). The synthesized cDNA was amplified by PCR using: the forward primer 5′-TCAGTGATGCTCACCCACAG-3′ and reverse primer 5′-CGTCATAGCCGTCGTTGTAA-3′ for <italic>dyrk1aa</italic>; the forward primer 5′-GAAACGACGGCATCAACAGG-3′ and reverse primer 5′-CAGCTCGGTCGTAGGCTTTT-3′ for <italic>dyrk1ab</italic>; the forward primer 5′-GGCAAGCTGACCCTGAAGTT-3′ and reverse primer 5′-TTCTGCTTGTCGGCCATGAT-3′ for <italic>EGFP</italic>; the forward primer 5′-CCCTTACCCTGGCTTACACA-3′ and reverse primer 5′-TCTTGTTGGTTCCGTTCTCC-3′ for <italic>kdrl</italic>; and the forward primer 5′-CTGGTTCAAGGGATGGAAGA-3′ and reverse primer 5′-ATGTGAGCAGTGTGGCAATC-3′ for <italic>eef1a1l1</italic>. The RT-PCR primers used for supplementary figures are shown in <uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">Table S4</uri>.</p>
</sec>
<sec id="s4e">
<title>Chemical treatment and small molecule library screening</title>
<p>Harmine (Sigma-Aldrich) was dissolved in DMSO and added to 1× PTU-E3 egg water to earn final concentrations of 10-50 µM with 0.1% DMSO, and then applied to ∼40 embryos (dechorionated) on a 90 mm plate from 24 to 52 hpf.</p>
<p>For chemical screening, each of 1280 small molecules in the Library of Pharmacologically Active Compounds (LOPAC1280, Sigma-Aldrich) with 10 µM as a final concentration was individually applied into each well of 48-well plates containing 1× PTU-E3 egg water with 30 µM harmine and five embryos from 24 to 52 hpf. As a negative control, 1× PTU-E3 egg water containing 0.4% DMSO was used. Upon 30 µM harmine treatment, on average three embryos displayed the hemorrhage in the brain regions. Based on this criterion, the increased hemorrhage was defined by four or five embryos showing the hemorrhage in brain regions, whereas the reduced phenotype was defined by 0 to two embryos with such defect.</p>
<p>For EGTA and FK506 treatment, EGTA at final concentrations of 1-100 nM and FK506 at final concentrations of 5-100 ng/ml was applied into each well of 6-well plates containing ∼20 dechorionated embryos of WT and <italic>dyrk1aa</italic> mutants from 24 to 52 hpf, with 1× PTU-E3 egg water containing 0.1% DMSO alone used as a negative control.</p>
</sec>
<sec id="s4f">
<title>Confocal microscopic analysis for cerebrovascular phenotypes of zebrafish embryos</title>
<p>To analyze the brain vasculature phenotypes of <italic>Tg(kdrl:EGFP)</italic> embryos with high resolution, embryos were grown up to 52 hpf and fixed with 1× staining solution (4% paraformaldehyde, 4% sucrose, 0.15 mM CaCl<sub>2</sub>, 1× PBS) overnight at 4°C. Fixed embryos were washed briefly with 1× PBST and embedded on glass-bottomed imaging dishes with 1% low melting point agarose (Promega). The embryos were imaged using Olympus FV1000 confocal microscopy and the CtA development in the hindbrain was quantified using the length and branching points, by measuring total lengths with ImageJ and manually counting the junctional sites of the CtAs.</p>
</sec>
<sec id="s4g">
<title>WISH and section of the hybridized embryos</title>
<p>WISH in zebrafish embryos was performed as previously reported (<xref ref-type="bibr" rid="DMM037044C77">Thisse and Thisse, 2008</xref>). The DNA templates for zebrafish <italic>dyrk1aa</italic>, <italic>dyrk1ab</italic> and <italic>dll4</italic> (GeneBank accession numbers BC129212.1, NM_001347831.1, and NM_001079835.1, respectively) were amplified from cDNA of WT embryos at 52 hpf. Prof. Cheol-Hee Kim (Chungnam National University, Republic of Korea) donated <italic>kdrl</italic>, <italic>krox20</italic> and <italic>isl1</italic> DNA. Dig-labeled anti-sense probes were <italic>in vitro</italic> transcribed using SP6 or T7 RNA polymerase kits (Roche) and purified with NucAway spin columns (Invitrogen). Embryos for WISH were prepared by fixing with 4% paraformaldehyde in 1× PBS, dehydrating using methanol, stored at −20°C for 30 min, and serially rehydrated using 1× PBST. The rehydrated embryos were treated with proteinase K in 1× PBS and post-fixed with 4% paraformaldehyde. The antisense probes were hybridized with the fixed embryos at each developmental stage in hybridizing solution (5 mg/ml torula yeast RNA type VI, 50 µg/ml heparin, 50% formamide, 5× SSC, 0.1% Tween-20, 1 M citric acid used to adjust to pH 6.0) at 70°C overnight. The probes were washed serially using 2× SSCT-F (2× SSCT, 50% formamide, 0.1% Tween-20), 2× SSCT (2× SSCT, 0.1% Tween-20), 0.2× SSCT (0.2× SSCT, 0.1% Tween-20) at 70°C and 1× PBST at RT. The embryos were blocked with blocking solution (5% horse serum, 1× PBST) at RT, and the alkaline phosphatase-conjugated anti-digoxigenin antibody (11 093 274 910, Roche) was added into the blocking solution at 4°C overnight. To detect the expression signal of transcripts, NBT/BCIP solution (11 681 451 001, Roche) was used as alkaline phosphatase substrate. The expression patterns of transcripts were observed using an Olympus SZX16 microscope and imaged with a TUCSEN Dhyana 400DC or Olympus XC10 camera. To observe detailed expression patterns, whole-mount RNA <italic>in situ</italic> hybridized embryos were prepared for cryosectioning by embedding in an agar-sucrose solution (1.5% agar, 5% sucrose). After the agar blocks containing the embryos were kept in 30% sucrose solution, they were processed for transverse cryosectioning using a LEICA CM1860 cryostat at a thickness of 25-35 µm.</p>
</sec>
<sec id="s4h">
<title>Microinjection of RNA</title>
<p>In order to prepare mRNAs of <italic>dyrk1aa</italic>, <italic>dyrk1aa-K193R</italic> and <italic>mCherryRed</italic> for rescue experiments, the pCS2+ vectors inserted with each DNA were linearized, <italic>in vitro</italic> transcribed using a mMESSAGE mMACHINE kit (Invitrogen) and purified with NucAway spin columns (Invitrogen). One-cell-stage eggs were collected and microinjected with each mRNA construct containing 0.05% Phenol Red solution as a visible indicator using a PV380 Pneumatic picopump (World Precision Instruments).</p>
</sec>
<sec id="s4i">
<title>Transmission electron microscopy</title>
<p>Tissue samples from embryos of WT and <italic>dyrk1aa<sup>krb1</sup></italic> at 48 hpf were fixed immediately with 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 h at 4°C. Following three washes in the phosphate buffer, tissues were post-fixed with 1% osmium tetroxide on ice for 2 h and washed three times in the phosphate buffer. The tissues were then embedded in pure Epon 812 mixture after dehydration in ethanol series and followed by infiltration in propylene oxide:epon mixture series. Polymerization was conducted with pure resin at 70°C for 24 h. Ultrathin sections (∼70 nm) were obtained with a model MT-X ultramicrotome (RMC Boeckeler) and then collected on 100 mesh copper grids. After staining with 2% uranyl acetate (7 min) and lead citrate (2 min), the sections were visualized using the Bio-HVEM system (JEM-1400Plus at 120 kV and JEM-1000BEF at 1000 kV, JEOL).</p>
</sec>
<sec id="s4j">
<title>Isolation, library preparation and sequencing for RNA-seq</title>
<p>Total RNA was isolated using Trizol reagent (Invitrogen). RNA quality was assessed by an Agilent 2100 bioanalyzer using the RNA 6000 Nano Chip (Agilent Technologies), and RNA quantification was performed using an ND-2000 Spectrophotometer (Thermo Fisher Scientific). For control and test RNAs, the construction of the library was performed using the SENSE mRNA-Seq Library Prep Kit (Lexogen) according to the manufacturer's instructions. Briefly, 2 μg total RNA are prepared and incubated with magnetic beads decorated with oligo-dT, and other RNAs except mRNA were removed by washing, and the mRNA was isolated from the oligo-dT bead of the poly(A) RNA selection kit (Lexogen). Library production was initiated by the random hybridization of starter/stopper heterodimers containing Illumina-compatible linker sequences to the poly (A) RNA bound to the magnetic beads. A single-tube reverse transcription and ligation reaction extends the starter to the next hybridized heterodimer, where the newly synthesized cDNA insert is ligated to the stopper. Second strand synthesis was performed to release the library from the beads, and the library was then amplified. Barcodes were introduced when the library was amplified. High-throughput sequencing was performed as paired-end 100 sequencing using HiSeq 2500 (Illumina). The sequenced reads were mapped to the University of California Santa Cruz zebrafish genome (<uri xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway?clade=vertebrate&amp;org=Zebrafish&amp;db=danRer10">danRer10</uri>) using STAR (v.2.5.1) (<xref ref-type="bibr" rid="DMM037044C17">Dobin et al., 2013</xref>), and the gene expression levels were quantified using the count module in STAR. The edgeR (v.3.12.1) (<xref ref-type="bibr" rid="DMM037044C69">Robinson et al., 2010</xref>) package was used to select differentially expressed genes from the RNA-seq count data. Meanwhile, the trimmed mean of M-values-normalized counts per million value of each gene was set to a baseline of 1 and log2-transformed for volcano plot drawing (<xref ref-type="fig" rid="DMM037044F7">Figs 7</xref>A and <uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">S7A</uri>).</p>
</sec>
<sec id="s4k">
<title>Statistical analyses</title>
<p>Statistical analyses of the data were performed using a Mann–Whitney <italic>U</italic> test or one-way ANOVA with Dunnett's multiple comparisons test using Prism software (Ver.7). Data are mean±s.e.m. with *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01 and ***<italic>P</italic>&lt;0.005.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<caption>
<title>Supplementary information</title>
</caption>
<media id="d35e2329" mime-subtype="pdf" mimetype="application" orientation="portrait" position="anchor" xlink:href="dmm-12-037044-s1.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors thank members of the Dr Lee and Dr Yu laboratories for helpful discussion on the manuscript.</p>
</ack>
<fn-group>
<title>Footnotes</title>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
<fn>
<p>
<bold>Author contributions</bold>
</p>
<p>Conceptualization: K.-S.L., K.Y., J.-S.L.; Methodology: H.-J.C., J.-G.L, J.-H.K., S.-Y.K., Y.H.H., H.-J.K., K.Y., J.-S.L.; Software: J.-H.K., S.-Y.K., J.-S.L.; Validation: J.-G.L., J.-S.L.; Formal analysis: J.-G.L., J.-H.K., S.-Y.K., Y.H.H., H.-J.K., K.Y.; Investigation: H.-J.C., J.-G.L., Y.H.H., K.-S.L., J.-S.L.; Resources: J.-S.L.; Data curation: H.-J.C., Y.H.H., K.-S.L., K.Y., J.-S.L.; Writing - original draft: H.-J.C., J.-H.K., S.-Y.K., Y.H.H., J.-S.L.; Writing - review &amp; editing: H.-J.C., J.-S.L.; Supervision: J.-S.L.; Project administration: J.-S.L.; Funding acquisition: J.-S.L.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>
<bold>Funding</bold>
</p>
<p>This work was supported by the National Research Foundation of Korea (NRF-2011-0023507) and the National Research Council of Science &amp; Technology (CRC-15-04-KIST), the Ministry of Science, ICT and Future Planning (MSIP) and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program.</p>
</fn>
<fn>
<p>
<bold>Data availability</bold>
</p>
<p>RNA-seq data have been deposited in GEO under accession number <ext-link ext-link-type="ncbi:geo" specific-use="dataset is-supplemented-by" xlink:href="GSE111280">GSE111280</ext-link>.</p>
</fn>
<fn fn-type="supplementary-material">
<p>
<bold>Supplementary information</bold>
</p>
<p>Supplementary information available online at <uri xlink:href="http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental">http://dmm.biologists.org/lookup/doi/10.1242/dmm.037044.supplemental</uri></p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="DMM037044C1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>AlMalki</surname><given-names>W. H.</given-names></name>, <name name-style="western"><surname>Shahid</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Mehdi</surname><given-names>A. Y.</given-names></name> and <name name-style="western"><surname>Hafeez</surname><given-names>M. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Assessment methods for angiogenesis and current approaches for its quantification</article-title>. <source/><italic toggle="yes">Indian J. Pharmacol.</italic>
<volume>46</volume>, <fpage>251</fpage>-<lpage>256</lpage>. <pub-id pub-id-type="doi">10.4103/0253-7613.132152</pub-id><pub-id pub-id-type="pmid">24987169</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>Niaudet</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>M.-F.</given-names></name>, <name name-style="western"><surname>Siegenthaler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gaengel</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ferrero</surname><given-names>G. M.</given-names></name>, <name name-style="western"><surname>Mukouyama</surname><given-names>Y. S.</given-names></name>, <name name-style="western"><surname>Fuxe</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Akhurst</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Excessive vascular sprouting underlies cerebral hemorrhage in mice lacking alphaVbeta8-TGFbeta signaling in the brain</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>141</volume>, <fpage>4489</fpage>-<lpage>4499</lpage>. <pub-id pub-id-type="doi">10.1242/dev.107193</pub-id><pub-id pub-id-type="pmid">25406396</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baek</surname><given-names>K.-H.</given-names></name>, <name name-style="western"><surname>Zaslavsky</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Britt</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Okada</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Siarey</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Lensch</surname><given-names>M. W.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>I.-H.</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>S. S.</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1</article-title>. <source/><italic toggle="yes">Nature</italic>
<volume>459</volume>, <fpage>1126</fpage>-<lpage>1130</lpage>. <pub-id pub-id-type="doi">10.1038/nature08062</pub-id><pub-id pub-id-type="pmid">19458618</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bain</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Plater</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shpiro</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Hastie</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>McLauchlan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Klevernic</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Arthur</surname><given-names>J. S. C.</given-names></name>, <name name-style="western"><surname>Alessi</surname><given-names>D. R.</given-names></name> and <name name-style="western"><surname>Cohen</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>The selectivity of protein kinase inhibitors: a further update</article-title>. <source/><italic toggle="yes">Biochem. J.</italic>
<volume>408</volume>, <fpage>297</fpage>-<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20070797</pub-id><pub-id pub-id-type="pmid">17850214</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrionuevo</surname><given-names>W. R.</given-names></name> and <name name-style="western"><surname>Burggren</surname><given-names>W. W.</given-names></name></person-group> (<year>1999</year>). <article-title>O2 consumption and heart rate in developing zebrafish (Danio rerio): influence of temperature and ambient O2</article-title>. <source/><italic toggle="yes">Am. J. Physiol.</italic>
<volume>276</volume>, <fpage>R505</fpage>-<lpage>R513</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.1999.276.2.r505</pub-id><pub-id pub-id-type="pmid">9950931</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berridge</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Lipp</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Bootman</surname><given-names>M. D.</given-names></name></person-group> (<year>2000</year>). <article-title>The versatility and universality of calcium signalling</article-title>. <source/><italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic>
<volume>1</volume>, <fpage>11</fpage>-<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/35036035</pub-id><pub-id pub-id-type="pmid">11413485</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bjorklund</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Kern</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Urbina</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Saad</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>El-Houfey</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Geier</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Chirumbolo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Geier</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Mehta</surname><given-names>J. A.</given-names></name> and <name name-style="western"><surname>Aaseth</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Cerebral hypoperfusion in autism spectrum disorder</article-title>. <source/><italic toggle="yes">Acta Neurobiol. Exp. (Wars.)</italic>
<volume>78</volume>, <fpage>21</fpage>-<lpage>29</lpage>. <pub-id pub-id-type="doi">10.21307/ane-2018-005</pub-id><pub-id pub-id-type="pmid">29694338</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bussmann</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>S. A.</given-names></name> and <name name-style="western"><surname>Siekmann</surname><given-names>A. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Arterial-venous network formation during brain vascularization involves hemodynamic regulation of chemokine signaling</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>138</volume>, <fpage>1717</fpage>-<lpage>1726</lpage>. <pub-id pub-id-type="doi">10.1242/dev.059881</pub-id><pub-id pub-id-type="pmid">21429983</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaoui</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Prenatal ultrasound diagnosis of Down syndrome. After major malformations, soft markers, nuchal translucency and skeletal signs, a new vascular sign?</article-title>
<source/><italic toggle="yes">Ultrasound Obstet. Gynecol.</italic>
<volume>26</volume>, <fpage>214</fpage>-<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1002/uog.1985</pub-id><pub-id pub-id-type="pmid">16116560</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clapham</surname><given-names>D. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Calcium signaling</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>131</volume>, <fpage>1047</fpage>-<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.11.028</pub-id><pub-id pub-id-type="pmid">18083096</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Skuster</surname><given-names>K. J.</given-names></name> and <name name-style="western"><surname>Ekker</surname><given-names>S. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Transgenic zebrafish using transposable elements</article-title>. <source/><italic toggle="yes">Methods Cell Biol.</italic>
<volume>104</volume>, <fpage>137</fpage>-<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-374814-0.00008-2</pub-id><pub-id pub-id-type="pmid">21924161</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Calcium, calcineurin, and the control of transcription</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>276</volume>, <fpage>2313</fpage>-<lpage>2316</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R000024200</pub-id><pub-id pub-id-type="pmid">11096121</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Borchgrave</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Saussu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Depre</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>de Barsy</surname><given-names>T.</given-names></name></person-group> (<year>2002</year>). <article-title>Moyamoya disease and Down syndrome: case report and review of the literature</article-title>. <source/><italic toggle="yes">Acta Neurol. Belg.</italic>
<volume>102</volume>, <fpage>63</fpage>-<lpage>66</lpage>.<pub-id pub-id-type="pmid">12161901</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dejana</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Tournier-Lasserve</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Weinstein</surname><given-names>B. M.</given-names></name></person-group> (<year>2009</year>). <article-title>The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications</article-title>. <source/><italic toggle="yes">Dev. Cell</italic>
<volume>16</volume>, <fpage>209</fpage>-<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2009.01.004</pub-id><pub-id pub-id-type="pmid">19217423</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deli</surname><given-names>M. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery</article-title>. <source/><italic toggle="yes">Biochim. Biophys. Acta</italic>
<volume>1788</volume>, <fpage>892</fpage>-<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2008.09.016</pub-id><pub-id pub-id-type="pmid">18983815</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dilling</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Roewer</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Förster</surname><given-names>C. Y.</given-names></name> and <name name-style="western"><surname>Burek</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Multiple protocadherins are expressed in brain microvascular endothelial cells and might play a role in tight junction protein regulation</article-title>. <source/><italic toggle="yes">J. Cereb. Blood Flow Metab.</italic>
<volume>37</volume>, <fpage>3391</fpage>-<lpage>3400</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16688706</pub-id><pub-id pub-id-type="pmid">28094605</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Schlesinger</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Drenkow</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zaleski</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Jha</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Batut</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Chaisson</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Gingeras</surname><given-names>T. R.</given-names></name></person-group> (<year>2013</year>). <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source/><italic toggle="yes">Bioinformatics</italic>
<volume>29</volume>, <fpage>15</fpage>-<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donahue</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Khurana</surname><given-names>J. S.</given-names></name> and <name name-style="western"><surname>Adelman</surname><given-names>L. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy</article-title>. <source/><italic toggle="yes">Acta Neuropathol.</italic>
<volume>95</volume>, <fpage>213</fpage>-<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1007/s004010050789</pub-id><pub-id pub-id-type="pmid">9498059</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ericson</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Thor</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Edlund</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Jessell</surname><given-names>T. M.</given-names></name> and <name name-style="western"><surname>Yamada</surname><given-names>T.</given-names></name></person-group> (<year>1992</year>). <article-title>Early stages of motor neuron differentiation revealed by expression of homeobox gene Islet-1</article-title>. <source/><italic toggle="yes">Science</italic>
<volume>256</volume>, <fpage>1555</fpage>-<lpage>1560</lpage>. <pub-id pub-id-type="doi">10.1126/science.1350865</pub-id><pub-id pub-id-type="pmid">1350865</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folkman</surname><given-names>J.</given-names></name></person-group> (<year>1995</year>). <article-title>Angiogenesis in cancer, vascular, rheumatoid and other disease</article-title>. <source/><italic toggle="yes">Nat. Med.</italic>
<volume>1</volume>, <fpage>27</fpage>-<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/nm0195-27</pub-id><pub-id pub-id-type="pmid">7584949</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fruen</surname><given-names>B. R.</given-names></name>, <name name-style="western"><surname>Mickelson</surname><given-names>J. R.</given-names></name> and <name name-style="western"><surname>Louis</surname><given-names>C. F.</given-names></name></person-group> (<year>1997</year>). <article-title>Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>272</volume>, <fpage>26965</fpage>-<lpage>26971</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.43.26965</pub-id><pub-id pub-id-type="pmid">9341133</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fujita</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cha</surname><given-names>Y. R.</given-names></name>, <name name-style="western"><surname>Pham</surname><given-names>V. N.</given-names></name>, <name name-style="western"><surname>Sakurai</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>B. L.</given-names></name>, <name name-style="western"><surname>Gutkind</surname><given-names>J. S.</given-names></name> and <name name-style="western"><surname>Weinstein</surname><given-names>B. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Assembly and patterning of the vascular network of the vertebrate hindbrain</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>138</volume>, <fpage>1705</fpage>-<lpage>1715</lpage>. <pub-id pub-id-type="doi">10.1242/dev.058776</pub-id><pub-id pub-id-type="pmid">21429985</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Kouklis</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Minshall</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Sandoval</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>S. M.</given-names></name> and <name name-style="western"><surname>Malik</surname><given-names>A. B.</given-names></name></person-group> (<year>2000</year>). <article-title>Reversibility of increased microvessel permeability in response to VE-cadherin disassembly</article-title>. <source/><italic toggle="yes">Am. J. Physiol. Lung Cell. Mol. Physiol.</italic>
<volume>279</volume>, <fpage>L1218</fpage>-<lpage>L1225</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.2000.279.6.L1218</pub-id><pub-id pub-id-type="pmid">11076812</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gjini</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hekking</surname><given-names>L. H.</given-names></name>, <name name-style="western"><surname>Kuchler</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Saharinen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wienholds</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Post</surname><given-names>J.-A.</given-names></name>, <name name-style="western"><surname>Alitalo</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Schulte-Merker</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity</article-title>. <source/><italic toggle="yes">Dis. Model Mech.</italic>
<volume>4</volume>, <fpage>57</fpage>-<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.005033</pub-id><pub-id pub-id-type="pmid">21045210</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Göckler</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Jofre</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Papadopoulos</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Soppa</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Tejedor</surname><given-names>F. J.</given-names></name> and <name name-style="western"><surname>Becker</surname><given-names>W.</given-names></name></person-group> (<year>2009</year>). <article-title>Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</article-title>. <source/><italic toggle="yes">FEBS J.</italic>
<volume>276</volume>, <fpage>6324</fpage>-<lpage>6337</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07346.x</pub-id><pub-id pub-id-type="pmid">19796173</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Görlach</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bertram</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hudecova</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Krizanova</surname><given-names>O.</given-names></name></person-group> (<year>2015</year>). <article-title>Calcium and ROS: a mutual interplay</article-title>. <source/><italic toggle="yes">Redox Biol.</italic>
<volume>6</volume>, <fpage>260</fpage>-<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2015.08.010</pub-id><pub-id pub-id-type="pmid">26296072</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gowda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>C.-H.</given-names></name> and <name name-style="western"><surname>Ross</surname><given-names>R. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Pulmonary vein stenosis with Down syndrome: a rare and frequently fatal cause of pulmonary hypertension in infants and children</article-title>. <source/><italic toggle="yes">Congenit. Heart Dis.</italic>
<volume>9</volume>, <fpage>E90</fpage>-<lpage>E97</lpage>. <pub-id pub-id-type="doi">10.1111/chd.12088</pub-id><pub-id pub-id-type="pmid">23650870</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grau</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Arato</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Fernandez-Fernandez</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Valderrama</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sindreu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>de la Luna</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors</article-title>. <source/><italic toggle="yes">Front Cell Neurosci.</italic>
<volume>8</volume>, <fpage>331</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00331</pub-id><pub-id pub-id-type="pmid">25368549</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hämmerle</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Elizalde</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Galceran</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>W.</given-names></name> and <name name-style="western"><surname>Tejedor</surname><given-names>F. J.</given-names></name></person-group> (<year>2003</year>). <article-title>The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications</article-title>. <source/><italic toggle="yes">J. Neural. Transm. Suppl.</italic>
<volume>67</volume>, <fpage>129</fpage>-<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-7091-6721-2_11</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hämmerle</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Elizalde</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Tejedor</surname><given-names>F. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development</article-title>. <source/><italic toggle="yes">Eur. J. Neurosci.</italic>
<volume>27</volume>, <fpage>1061</fpage>-<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06092.x</pub-id><pub-id pub-id-type="pmid">18364031</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harvey</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Sealy</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kettleborough</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Fenyes</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Stemple</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Smith</surname><given-names>J. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Identification of the zebrafish maternal and paternal transcriptomes</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>140</volume>, <fpage>2703</fpage>-<lpage>2710</lpage>. <pub-id pub-id-type="doi">10.1242/dev.095091</pub-id><pub-id pub-id-type="pmid">23720042</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasle</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Clemmensen</surname><given-names>I. H.</given-names></name> and <name name-style="western"><surname>Mikkelsen</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Risks of leukaemia and solid tumours in individuals with Down's syndrome</article-title>. <source/><italic toggle="yes">Lancet</italic>
<volume>355</volume>, <fpage>165</fpage>-<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(99)05264-2</pub-id><pub-id pub-id-type="pmid">10675114</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A-alternative splicing factor-calcium/calmodulin-dependent protein kinase IIdelta signaling pathway in myocardial infarction-induced heart failure of rats</article-title>. <source/><italic toggle="yes">J. Card. Fail.</italic>
<volume>21</volume>, <fpage>751</fpage>-<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardfail.2015.05.015</pub-id><pub-id pub-id-type="pmid">26067684</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Himpel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Panzer</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Eirmbter</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Czajkowska</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sayed</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Packman</surname><given-names>L. C.</given-names></name>, <name name-style="western"><surname>Blundell</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kentrup</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Grotzinger</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Joost</surname><given-names>H. G.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A</article-title>. <source/><italic toggle="yes">Biochem. J.</italic>
<volume>359</volume>, <fpage>497</fpage>-<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1042/bj3590497</pub-id><pub-id pub-id-type="pmid">11672423</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hogan</surname><given-names>B. M.</given-names></name> and <name name-style="western"><surname>Schulte-Merker</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>How to plumb a pisces: understanding vascular development and disease using zebrafish embryos</article-title>. <source/><italic toggle="yes">Dev. Cell</italic>
<volume>42</volume>, <fpage>567</fpage>-<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2017.08.015</pub-id><pub-id pub-id-type="pmid">28950100</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hogan</surname><given-names>P. G.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Nardone</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Transcriptional regulation by calcium, calcineurin, and NFAT</article-title>. <source/><italic toggle="yes">Genes Dev.</italic>
<volume>17</volume>, <fpage>2205</fpage>-<lpage>2232</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1102703</pub-id><pub-id pub-id-type="pmid">12975316</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hogan</surname><given-names>B. M.</given-names></name>, <name name-style="western"><surname>Verkade</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lieschke</surname><given-names>G. J.</given-names></name> and <name name-style="western"><surname>Heath</surname><given-names>J. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Manipulation of gene expression during zebrafish embryonic development using transient approaches</article-title>. <source/><italic toggle="yes">Methods Mol. Biol.</italic>
<volume>469</volume>, <fpage>273</fpage>-<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60327-469-2_19</pub-id><pub-id pub-id-type="pmid">19109716</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hatta</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hotta</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Okamoto</surname><given-names>H.</given-names></name></person-group> (<year>1994</year>). <article-title>Developmental regulation of islet-1 mRNA expression during neuronal differentiation in embryonic zebrafish</article-title>. <source/><italic toggle="yes">Dev. Dyn.</italic>
<volume>199</volume>, <fpage>1</fpage>-<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/aja.1001990102</pub-id><pub-id pub-id-type="pmid">8167375</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inzitari</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Poggesi</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Calcium channel blockers and stroke</article-title>. <source/><italic toggle="yes">Aging Clin. Exp. Res.</italic>
<volume>17</volume>, <fpage>16</fpage>-<lpage>30</lpage>.<pub-id pub-id-type="pmid">16640170</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isogai</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Horiguchi</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Weinstein</surname><given-names>B. M.</given-names></name></person-group> (<year>2001</year>). <article-title>The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development</article-title>. <source/><italic toggle="yes">Dev. Biol.</italic>
<volume>230</volume>, <fpage>278</fpage>-<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1006/dbio.2000.9995</pub-id><pub-id pub-id-type="pmid">11161578</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jastrzebski</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kacperska</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Majos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Grodzka</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Glabiński</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Hemorrhagic stroke, cerebral amyloid angiopathy, Down syndrome and the Boston criteria</article-title>. <source/><italic toggle="yes">Neurol. Neurochir. Pol.</italic>
<volume>49</volume>, <fpage>193</fpage>-<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.pjnns.2015.04.006</pub-id><pub-id pub-id-type="pmid">26048609</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.-I.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S.-G.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.-J.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>S.-L.</given-names></name>, <name name-style="western"><surname>Ha</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Kim</surname><given-names>S. S.</given-names></name></person-group> (<year>1999</year>). <article-title>Mannan-binding lectin (MBL)-associated plasma protein present in human urine inhibits calcium oxalate crystal growth</article-title>. <source/><italic toggle="yes">FEBS Lett.</italic>
<volume>462</volume>, <fpage>89</fpage>-<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(99)01509-4</pub-id><pub-id pub-id-type="pmid">10580098</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khorchid</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Ikura</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>How calpain is activated by calcium</article-title>. <source/><italic toggle="yes">Nat. Struct. Biol.</italic>
<volume>9</volume>, <fpage>239</fpage>-<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/nsb0402-239</pub-id><pub-id pub-id-type="pmid">11914728</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>O.-H.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>H.-J.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>T. I.</given-names></name>, <name name-style="western"><surname>Ariyasiri</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>K.-S.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>Y.-M.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S.-Y.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>). <article-title>Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism</article-title>. <source/><italic toggle="yes">Mol. Autism</italic>
<volume>8</volume>, <fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-017-0168-2</pub-id><pub-id pub-id-type="pmid">29021890</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korzh</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Edlund</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Thor</surname><given-names>S.</given-names></name></person-group> (<year>1993</year>). <article-title>Zebrafish primary neurons initiate expression of the LIM homeodomain protein Isl-1 at the end of gastrulation</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>118</volume>, <fpage>417</fpage>-<lpage>425</lpage>.<pub-id pub-id-type="pmid">8223269</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Hogan</surname><given-names>P. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Interaction of calcineurin with substrates and targeting proteins</article-title>. <source/><italic toggle="yes">Trends Cell Biol.</italic>
<volume>21</volume>, <fpage>91</fpage>-<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2010.09.011</pub-id><pub-id pub-id-type="pmid">21115349</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Faloon</surname><given-names>P. W.</given-names></name>, <name name-style="western"><surname>Rollins</surname><given-names>E. L.</given-names></name>, <name name-style="western"><surname>Vom Berg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Starovic-Subota</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Laliberte</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.-N.</given-names></name>, <name name-style="western"><surname>Serluca</surname><given-names>F. C.</given-names></name> and <name name-style="western"><surname>Childs</surname><given-names>S. J.</given-names></name></person-group> (<year>2007</year>). <article-title>A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>104</volume>, <fpage>13990</fpage>-<lpage>13995</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0700825104</pub-id><pub-id pub-id-type="pmid">17573532</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wegiel</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>Y. W.</given-names></name>, <name name-style="western"><surname>Iqbal</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Grundke-Iqbal</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ramakrishna</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Gong</surname><given-names>C. X.</given-names></name></person-group> (<year>2008</year>). <article-title>Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome</article-title>. <source/><italic toggle="yes">FASEB J.</italic>
<volume>22</volume>, <fpage>3224</fpage>-<lpage>3233</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-104539</pub-id><pub-id pub-id-type="pmid">18509201</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loh</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>K. T.-Y.</given-names></name>, <name name-style="western"><surname>Carew</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Viola</surname><given-names>J. P. B.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Perrino</surname><given-names>B. A.</given-names></name> and <name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name></person-group> (<year>1996</year>). <article-title>Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>271</volume>, <fpage>10884</fpage>-<lpage>10891</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.18.10884</pub-id><pub-id pub-id-type="pmid">8631904</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lounsbury</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Q.</given-names></name> and <name name-style="western"><surname>Ziegelstein</surname><given-names>R. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Calcium signaling and oxidant stress in the vasculature</article-title>. <source/><italic toggle="yes">Free Radic. Biol. Med.</italic>
<volume>28</volume>, <fpage>1362</fpage>-<lpage>1369</lpage>. <pub-id pub-id-type="doi">10.1016/S0891-5849(00)00222-7</pub-id><pub-id pub-id-type="pmid">10924855</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacRae</surname><given-names>C. A.</given-names></name> and <name name-style="western"><surname>Peterson</surname><given-names>R. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Zebrafish as tools for drug discovery</article-title>. <source/><italic toggle="yes">Nat. Rev. Drug Discov.</italic>
<volume>14</volume>, <fpage>721</fpage>-<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1038/nrd4627</pub-id><pub-id pub-id-type="pmid">26361349</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manoli</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Driever</surname><given-names>W.</given-names></name></person-group> (<year>2012</year>). <article-title>Fluorescence-activated cell sorting (FACS) of fluorescently tagged cells from zebrafish larvae for RNA isolation</article-title>. <source/><italic toggle="yes">Cold Spring Harb. Protoc.</italic>
<volume>2012</volume>, <fpage>pdb.prot069633</fpage>
<pub-id pub-id-type="doi">10.1101/pdb.prot069633</pub-id><pub-id pub-id-type="pmid">22854565</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marti</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Altafaj</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Dierssen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>de la Luna</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fotaki</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Alvarez</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pérez-Riba</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Estivill</surname><given-names>X.</given-names></name></person-group> (<year>2003</year>). <article-title>Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system</article-title>. <source/><italic toggle="yes">Brain Res.</italic>
<volume>964</volume>, <fpage>250</fpage>-<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(02)04069-6</pub-id><pub-id pub-id-type="pmid">12576186</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathavan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S. G. P.</given-names></name>, <name name-style="western"><surname>Mak</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>L. D.</given-names></name>, <name name-style="western"><surname>Murthy</surname><given-names>K. R. K.</given-names></name>, <name name-style="western"><surname>Govindarajan</surname><given-names>K. R.</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y. L.</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2005</year>). <article-title>Transcriptome analysis of zebrafish embryogenesis using microarrays</article-title>. <source/><italic toggle="yes">PLoS Genet.</italic>
<volume>1</volume>, <fpage>260</fpage>-<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0010029</pub-id><pub-id pub-id-type="pmid">16132083</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minami</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Horiuchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Miura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Abid</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Takabe</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Noguchi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Kohro</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Aburatani</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hamakubo</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>). <article-title>Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>279</volume>, <fpage>50537</fpage>-<lpage>50554</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M406454200</pub-id><pub-id pub-id-type="pmid">15448146</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mito</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Becker</surname><given-names>L. E.</given-names></name></person-group> (<year>1992</year>). <article-title>Vascular dysplasia in Down syndrome: a possible relationship to moyamoya disease</article-title>. <source/><italic toggle="yes">Brain Dev.</italic>
<volume>14</volume>, <fpage>248</fpage>-<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/S0387-7604(12)80239-7</pub-id><pub-id pub-id-type="pmid">1443405</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moens</surname><given-names>C. B.</given-names></name> and <name name-style="western"><surname>Prince</surname><given-names>V. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Constructing the hindbrain: insights from the zebrafish</article-title>. <source/><italic toggle="yes">Dev. Dyn.</italic>
<volume>224</volume>, <fpage>1</fpage>-<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.10086</pub-id><pub-id pub-id-type="pmid">11984869</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munaron</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Intracellular calcium, endothelial cells and angiogenesis</article-title>. <source/><italic toggle="yes">Recent Pat. Anticancer Drug. Discov.</italic>
<volume>1</volume>, <fpage>105</fpage>-<lpage>119</lpage>. <pub-id pub-id-type="doi">10.2174/157489206775246502</pub-id><pub-id pub-id-type="pmid">18221030</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nižetić</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Groet</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Tumorigenesis in Down's syndrome: big lessons from a small chromosome</article-title>. <source/><italic toggle="yes">Nat. Rev. Cancer</italic>
<volume>12</volume>, <fpage>721</fpage>-<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3355</pub-id><pub-id pub-id-type="pmid">22996602</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orr</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Arnaout</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gula</surname><given-names>L. J.</given-names></name>, <name name-style="western"><surname>Spears</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Leong-Sit</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Tarhuni</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Reischauer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chauhan</surname><given-names>V. S.</given-names></name>, <name name-style="western"><surname>Borkovich</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation</article-title>. <source/><italic toggle="yes">Nat. Commun.</italic>
<volume>7</volume>, <fpage>11303</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms11303</pub-id><pub-id pub-id-type="pmid">27066836</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oxtoby</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Jowett</surname><given-names>T.</given-names></name></person-group> (<year>1993</year>). <article-title>Cloning of the zebrafish krox-20 gene (krx-20) and its expression during hindbrain development</article-title>. <source/><italic toggle="yes">Nucleic Acids Res.</italic>
<volume>21</volume>, <fpage>1087</fpage>-<lpage>1095</lpage>. <pub-id pub-id-type="doi">10.1093/nar/21.5.1087</pub-id><pub-id pub-id-type="pmid">8464695</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandya</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Dhalla</surname><given-names>N. S.</given-names></name> and <name name-style="western"><surname>Santani</surname><given-names>D. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Angiogenesis--a new target for future therapy</article-title>. <source/><italic toggle="yes">Vascul. Pharmacol.</italic>
<volume>44</volume>, <fpage>265</fpage>-<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2006.01.005</pub-id><pub-id pub-id-type="pmid">16545987</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phng</surname><given-names>L.-K.</given-names></name>, <name name-style="western"><surname>Potente</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Leslie</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Babbage</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nyqvist</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lobov</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ondr</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Thurston</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis</article-title>. <source/><italic toggle="yes">Dev. Cell</italic>
<volume>16</volume>, <fpage>70</fpage>-<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2008.12.009</pub-id><pub-id pub-id-type="pmid">19154719</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pipitone</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Garofalo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Corsello</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mongiovì</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Piccione</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Maresi</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Sperandeo</surname><given-names>V.</given-names></name></person-group> (<year>2003</year>). <article-title>Abnormalities of the umbilico-portal venous system in Down syndrome: a report of two new patients</article-title>. <source/><italic toggle="yes">Am. J. Med. Genet. A</italic>
<volume>120A</volume>, <fpage>528</fpage>-<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.20081</pub-id><pub-id pub-id-type="pmid">12884433</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quaegebeur</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lange</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Carmeliet</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>The neurovascular link in health and disease: molecular mechanisms and therapeutic implications</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>71</volume>, <fpage>406</fpage>-<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.07.013</pub-id><pub-id pub-id-type="pmid">21835339</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahmani</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lopes</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rachidi</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Delabar</surname><given-names>J.-M.</given-names></name></person-group> (<year>1998</year>). <article-title>Expression of the mnb (dyrk) protein in adult and embryonic mouse tissues</article-title>. <source/><italic toggle="yes">Biochem. Biophys. Res. Commun.</italic>
<volume>253</volume>, <fpage>514</fpage>-<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1998.9803</pub-id><pub-id pub-id-type="pmid">9878567</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathore</surname><given-names>M. H.</given-names></name> and <name name-style="western"><surname>Sreenivasan</surname><given-names>V. V.</given-names></name></person-group> (<year>1989</year>). <article-title>Vertebral and right subclavian artery abnormalities in the Down syndrome</article-title>. <source/><italic toggle="yes">Am. J. Cardiol.</italic>
<volume>63</volume>, <fpage>1528</fpage>-<lpage>1529</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9149(89)90023-4</pub-id><pub-id pub-id-type="pmid">2524962</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reid</surname><given-names>I. R.</given-names></name> and <name name-style="western"><surname>Bolland</surname><given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Calcium supplementation and vascular disease</article-title>. <source/><italic toggle="yes">Climacteric</italic>
<volume>11</volume>, <fpage>280</fpage>-<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1080/13697130802229639</pub-id><pub-id pub-id-type="pmid">18645693</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>D. J.</given-names></name> and <name name-style="western"><surname>Smyth</surname><given-names>G. K.</given-names></name></person-group> (<year>2010</year>). <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source/><italic toggle="yes">Bioinformatics</italic>
<volume>26</volume>, <fpage>139</fpage>-<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rozen</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Roewenstrunk</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Barallobre</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Di Vona</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Figueiredo</surname><given-names>A. F.</given-names></name>, <name name-style="western"><surname>Luna</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Fillat</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Arbones</surname><given-names>M. L.</given-names></name>, <name name-style="western"><surname>Graupera</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>). <article-title>DYRK1A kinase positively regulates angiogenic responses in endothelial cells</article-title>. <source/><italic toggle="yes">Cell Rep.</italic>
<volume>23</volume>, <fpage>1867</fpage>-<lpage>1878</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.008</pub-id><pub-id pub-id-type="pmid">29742440</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabde</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tullu</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Lahiri</surname><given-names>K. R.</given-names></name> and <name name-style="western"><surname>Vaswani</surname><given-names>R. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Moyamoya syndrome in a child with Down syndrome</article-title>. <source/><italic toggle="yes">Arch. Med. Res.</italic>
<volume>36</volume>, <fpage>421</fpage>-<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.arcmed.2005.03.003</pub-id><pub-id pub-id-type="pmid">15950086</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Strähle</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Scholpp</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Neurogenesis in zebrafish - from embryo to adult</article-title>. <source/><italic toggle="yes">Neural Dev.</italic>
<volume>8</volume>, <fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/1749-8104-8-3</pub-id><pub-id pub-id-type="pmid">23433260</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Rigor</surname><given-names>R. R.</given-names></name>, <name name-style="western"><surname>Pivetti</surname><given-names>C. D.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>M. H.</given-names></name> and <name name-style="western"><surname>Yuan</surname><given-names>S. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Myosin light chain kinase in microvascular endothelial barrier function</article-title>. <source/><italic toggle="yes">Cardiovasc. Res.</italic>
<volume>87</volume>, <fpage>272</fpage>-<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvq144</pub-id><pub-id pub-id-type="pmid">20479130</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sobey</surname><given-names>C. G.</given-names></name>, <name name-style="western"><surname>Judkins</surname><given-names>C. P.</given-names></name>, <name name-style="western"><surname>Sundararajan</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Phan</surname><given-names>T. G.</given-names></name>, <name name-style="western"><surname>Drummond</surname><given-names>G. R.</given-names></name> and <name name-style="western"><surname>Srikanth</surname><given-names>V. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Risk of major cardiovascular events in people with down syndrome</article-title>. <source/><italic toggle="yes">PLoS One</italic>
<volume>10</volume>, <fpage>e0137093</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0137093</pub-id><pub-id pub-id-type="pmid">26421620</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Calder</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Neutze</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>James</surname><given-names>A. H.</given-names></name> and <name name-style="western"><surname>Brandt</surname><given-names>P. W. T.</given-names></name></person-group> (<year>1992</year>). <article-title>Stenosis of pulmonary veins in Down syndrome</article-title>. <source/><italic toggle="yes">J. Paediatr. Child Health</italic>
<volume>28</volume>, <fpage>192</fpage>-<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1754.1992.tb02641.x</pub-id><pub-id pub-id-type="pmid">1532897</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tejedor</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X. R.</given-names></name>, <name name-style="western"><surname>Kaltenbach</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ackermann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Baumann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Canal</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Heisenberg</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>K. F.</given-names></name> and <name name-style="western"><surname>Pongs</surname><given-names>O.</given-names></name></person-group> (<year>1995</year>). <article-title>minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>14</volume>, <fpage>287</fpage>-<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90286-4</pub-id><pub-id pub-id-type="pmid">7857639</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thisse</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Thisse</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title>. <source/><italic toggle="yes">Nat. Protoc.</italic>
<volume>3</volume>, <fpage>59</fpage>-<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tímár</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dome</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Fazekas</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Janovics</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Paku</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Angiogenesis-dependent diseases and angiogenesis therapy</article-title>. <source/><italic toggle="yes">Pathol. Oncol. Res.</italic>
<volume>7</volume>, <fpage>85</fpage>-<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1007/BF03032573</pub-id><pub-id pub-id-type="pmid">11458270</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Timme-Laragy</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Karchner</surname><given-names>S. I.</given-names></name> and <name name-style="western"><surname>Hahn</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Gene knockdown by morpholino-modified oligonucleotides in the zebrafish (Danio rerio) model: applications for developmental toxicology</article-title>. <source/><italic toggle="yes">Methods Mol. Biol.</italic>
<volume>889</volume>, <fpage>51</fpage>-<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-867-2_5</pub-id><pub-id pub-id-type="pmid">22669659</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tiruppathi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Minshall</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Paria</surname><given-names>B. C.</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>S. M.</given-names></name> and <name name-style="western"><surname>Malik</surname><given-names>A. B.</given-names></name></person-group> (<year>2002</year>). <article-title>Role of Ca2+ signaling in the regulation of endothelial permeability</article-title>. <source/><italic toggle="yes">Vascul. Pharmacol.</italic>
<volume>39</volume>, <fpage>173</fpage>-<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/S1537-1891(03)00007-7</pub-id><pub-id pub-id-type="pmid">12747958</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomita</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hayashi</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Awazu</surname><given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells</article-title>. <source/><italic toggle="yes">J. Pharm. Sci.</italic>
<volume>85</volume>, <fpage>608</fpage>-<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1021/js9504604</pub-id><pub-id pub-id-type="pmid">8773957</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Udan</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Culver</surname><given-names>J. C.</given-names></name> and <name name-style="western"><surname>Dickinson</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Understanding vascular development</article-title>. <source/><italic toggle="yes">Wiley Interdiscip. Rev. Dev. Biol.</italic>
<volume>2</volume>, <fpage>327</fpage>-<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.91</pub-id><pub-id pub-id-type="pmid">23799579</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ulrich</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L.-H.</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>R. G.</given-names></name> and <name name-style="western"><surname>Torres-Vázquez</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Neurovascular development in the embryonic zebrafish hindbrain</article-title>. <source/><italic toggle="yes">Dev. Biol.</italic>
<volume>357</volume>, <fpage>134</fpage>-<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2011.06.037</pub-id><pub-id pub-id-type="pmid">21745463</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varshney</surname><given-names>G. K.</given-names></name>, <name name-style="western"><surname>Sood</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Burgess</surname><given-names>S. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Understanding and editing the zebrafish genome</article-title>. <source/><italic toggle="yes">Adv. Genet.</italic>
<volume>92</volume>, <fpage>1</fpage>-<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/bs.adgen.2015.09.002</pub-id><pub-id pub-id-type="pmid">26639914</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Aurora</surname><given-names>A. B.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>B. A.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>McAnally</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Bassel-Duby</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Olson</surname><given-names>E. N.</given-names></name></person-group> (<year>2008</year>). <article-title>The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis</article-title>. <source/><italic toggle="yes">Dev. Cell</italic>
<volume>15</volume>, <fpage>261</fpage>-<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2008.07.002</pub-id><pub-id pub-id-type="pmid">18694565</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Moens</surname><given-names>C. B.</given-names></name> and <name name-style="western"><surname>Appel</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Notch3 establishes brain vascular integrity by regulating pericyte number</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>141</volume>, <fpage>307</fpage>-<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1242/dev.096107</pub-id><pub-id pub-id-type="pmid">24306108</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wegiel</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>C.-X.</given-names></name> and <name name-style="western"><surname>Hwang</surname><given-names>Y.-W.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of DYRK1A in neurodegenerative diseases</article-title>. <source/><italic toggle="yes">FEBS J.</italic>
<volume>278</volume>, <fpage>236</fpage>-<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07955.x</pub-id><pub-id pub-id-type="pmid">21156028</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Z.</given-names></name> and <name name-style="western"><surname>Michaely</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>The role of calcium in lipoprotein release by the low-density lipoprotein receptor</article-title>. <source/><italic toggle="yes">Biochemistry</italic>
<volume>48</volume>, <fpage>7313</fpage>-<lpage>7324</lpage>. <pub-id pub-id-type="doi">10.1021/bi900214u</pub-id><pub-id pub-id-type="pmid">19583244</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zilbovicius</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Boddaert</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Belin</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Poline</surname><given-names>J. B.</given-names></name>, <name name-style="western"><surname>Remy</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mangin</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Thivard</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Barthelemy</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Samson</surname><given-names>Y.</given-names></name></person-group> (<year>2000</year>). <article-title>Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography</article-title>. <source/><italic toggle="yes">Am. J. Psychiatry</italic>
<volume>157</volume>, <fpage>1988</fpage>-<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.157.12.1988</pub-id><pub-id pub-id-type="pmid">11097965</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zlokovic</surname><given-names>B. V.</given-names></name></person-group> (<year>2008</year>). <article-title>The blood-brain barrier in health and chronic neurodegenerative disorders</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>57</volume>, <fpage>178</fpage>-<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.01.003</pub-id><pub-id pub-id-type="pmid">18215617</pub-id></mixed-citation>
</ref>
<ref id="DMM037044C91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>TALEN-mediated precise genome modification by homologous recombination in zebrafish</article-title>. <source/><italic toggle="yes">Nat. Methods</italic>
<volume>10</volume>, <fpage>329</fpage>-<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2374</pub-id><pub-id pub-id-type="pmid">23435258</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>